Regulation of Intestinal Barrier Function by Microbial Metabolites
Open accessAbstract
The human gastrointestinal tract (GI) harbors a diverse population of microbial life that continually shapes host pathophysiological responses. Despite readily available abundant metagenomic data, the functional dynamics of gut microbiota remain to be explored in various health and disease conditions. Microbiota generate a variety of metabolites from dietary products that influence host health and pathophysiological functions. Since gut microbial metabolites are produced in close proximity to gut epithelium, presumably they have significant impact on gut barrier function and immune responses. The goal of this review is to discuss recent advances on gut microbial metabolites in the regulation of intestinal barrier function. While the mechanisms of action of these metabolites are only beginning to emerge, they mainly point to a small group of shared pathways that control gut barrier functions. Amidst expanding technology and broadening knowledge, exploitation of beneficial microbiota and their metabolites to restore pathophysiological balance will likely prove to be an extremely useful remedial tool.
AI snapshot
Written from the paper’s full text.
TL;DR
This review summarizes how gut microbial metabolites regulate intestinal barrier function through shared pathways and discusses potential therapeutic strategies. It highlights metabolites such as SCFAs, indole derivatives, bile acids, conjugated fatty acids, polyamines, and polyphenolic derivatives, while noting that mechanisms and clinical translation remain early.
Key findings
- The gut barrier comprises mucus, epithelial, and mucosal immune layers; junctional complexes (tight junctions, adherens junctions, desmosomes, gap junctions) regulate paracellular permeability via the pore pathway (excludes molecules ≤8 Å), the leak pathway (exclusion limit ∼100 Å), and an unrestricted pathway from IEC death.
- Microbial metabolites influence barrier function: butyrate at 1–10 mM improved epithelial barrier function and increased MUC2 in E12 human colon cells, whereas 50–100 mM showed no beneficial effect; indole levels in fecal samples of germ-free mice were 27-fold lower than conventionally raised mice, and indole supplementation restored junctional protein expression; UroA enhanced TJ proteins via an AhR-Nrf2–dependent pathway and mitigated DSS- or TNBS-induced colitis; DCA increased gut permeability >1.5-fold, while UDCA blocked DCA-induced permeability.
- Bacterial structural components signal through TLRs and NLRs: TLR2 activation increases TEER and TJ sealing; LPS/TLR4 disrupts junctional complexes and increases permeability; TLR5/flagellin and NOD1/NOD2 also modulate barrier integrity, with Nod1−/− and Nod2−/− mice showing increased paracellular permeability and DSS colitis susceptibility.
- Treatment strategies include FMT, probiotics, UroA/UAS03, divertin, hormone treatment, and dietary supplements, but the review states that no microbial metabolites or their analogues are in clinical use.
Methods
- Narrative review; no primary experimental data. It synthesizes recent advances on gut microbial metabolites and intestinal barrier function, with tables of intestinal cell types, junctional components, and microbial metabolites, plus figures of pathways and treatment strategies.
- Cites preclinical and human studies, including cell lines (Caco-2, T84, E12), mouse models (germ-free, DSS/TNBS colitis, AhR−/−, Nrf2−/−, etc.), piglet models, and human trials/observations.
- Main analysis is qualitative synthesis of the literature; no systematic search strategy or meta-analysis is described.
Limitations
- The paper states that mechanisms of action of these metabolites are only beginning to emerge and that detailed mechanisms are yet to be elucidated.
- The paper states that no microbial metabolites or their analogues are in clinical use, that UroA production and function in vivo have yet to be directly determined using gnotobiotic animals, and that extensive longitudinal studies are needed.
- Evident from the text: as a narrative review, it does not provide systematic search criteria, risk-of-bias assessment, or quantitative synthesis; conclusions rely on cited studies with varying models, doses, and species.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 187 cited sources checked · 0 supported · 0 flagged
- Premisecitation
Intestinal epithelial cells allow selective penetration of nutrients, water, and electrolytes while simultaneously excluding microbial pathogen-associated molecular pattern, toxins, and foreign antigens.
“Intestinal epithelial cells (IECs) allow for selective penetration of nutrients, water, and electrolytes while simultaneously excluding microbial pathogen-associated molecular pattern, toxins, and foreign antigens.30”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Kunzelmann, 2002, Electrolyte transport in the mammalian colon: mechanisms and implications for disease, Physiol Rev source
Not checked in the free run.
- Premisecitation
Fecal microbiota transplantation from healthy hosts is positively correlated with disease reversal, especially those stemming from gut barrier dysfunction like IBD, IBS, celiac disease, and Clostridium difficile infections.
“Studies have revealed that fecal microbiota transplantation (FMT) from healthy hosts are positively correlated with disease reversal, especially those stemming from gut barrier dysfunction like IBD, IBS, celiac disease, and Clostridium difficile infections.19,20”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [19] Moayyedi, 2015, Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial, Gastroenterology source
Not checked in the free run.
- cites [20] Kim, 2019, Fecal microbiota transplantation in recurrent Clostridium difficile infection: a retrospective single-center chart review, JGH Open source
Not checked in the free run.
- Premisecitation
Gut barrier dysfunction is strongly correlated with autoimmune, inflammatory, and metabolic diseases such as diabetes, obesity, atherosclerosis, heart failure, hypertension, and food allergies, as well as with cancer.
“Gut barrier dysfunction is also strongly correlated with other autoimmune, inflammatory, and metabolic diseases such as diabetes, obesity, atherosclerosis, heart failure, hypertension, and food allergies, as well as with cancer.10,11”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [10] Gopalakrishnan, 2018, The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy, Cancer Cell source
Not checked in the free run.
- cites [11] Martini, 2017, Mend your fences: the epithelial barrier and its relationship with mucosal immunity in inflammatory bowel disease, Cell Mol Gastroenterol Hepatol source
Not checked in the free run.
- Premisenone given
Microbiota significantly influence the functions of the intestinal barrier that separates internal organs from harmful entities including microorganisms, luminal antigens, and luminal proinflammatory factors.
“Microbiota significantly influence the functions of the intestinal barrier that separates internal organs from harmful entities including microorganisms, luminal antigens, and luminal proinflammatory factors.”
Quote in the paperNot a substantial claim - Interpretationnone given
The gut microbiota and their metabolites significantly regulate the pore and leak pathways leading to either enhancement or reduction of gut barrier function.
“The gut microbiota and their metabolites significantly regulate these pathways leading to either enhancement or reduction of gut barrier function.”
Quote in the paperNot a substantial claim
- Premisecitation
One major function of the gut microbiota is metabolism of dietary components leading to the generation of active metabolites that directly regulate human physiology including gut barrier function.
“One of the major functions of the gut microbiota is metabolism of dietary components leading to the generation of active metabolites that directly regulate human physiology including gut barrier function.21”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21] Maurice, 2013, Xenobiotics shape the physiology and gene expression of the active human gut microbiome, Cell source
Not checked in the free run.
- Premisecitation
Increasing culture-independent omic-based technologies have facilitated the discovery of novel functional dynamics of microbiota and their relationship with host pathophysiology.
“Increasing culture-independent omic-based technologies such as biomarker sequencing, metagenomics, metatranscriptomics, metaproteomics, and metabolomics have facilitated the discovery of novel functional dynamics of microbiota2, 3, 4, 5 and their relationship with host pathophysiology.6, 7, 8, 9”
Quote in the paperNot a substantial claim0 of 8 sources checked- cites [2] Oh, 2014, Biogeography and individuality shape function in the human skin metagenome, Nature source
Not checked in the free run.
- cites [3] Lynch, 2016, The human intestinal microbiome in health and disease, N Engl J Med source
Not checked in the free run.
- cites [4] 2012, Structure, function and diversity of the healthy human microbiome, Nature source
Not checked in the free run.
- cites [5] Eckburg, 2005, Diversity of the human intestinal microbial flora, Science source
Not checked in the free run.
- cites [6] Kamada, 2013, Control of pathogens and pathobionts by the gut microbiota, Nat Immunol source
Not checked in the free run.
- cites [7] Ha, 2014, Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health, World J Gastroenterol source
Not checked in the free run.
- cites [8] Wu, 2015, Linking microbiota to human diseases: a systems biology perspective, Trends Endocrinol Metab source
Not checked in the free run.
- cites [9] Claesson, 2012, Gut microbiota composition correlates with diet and health in the elderly, Nature source
Not checked in the free run.
- Premisecitation
Solutes and water cross tight junctions through 2 distinct pathways based on their size and charge selectivity: the pore pathway and the leak pathway.
“It was reported that solutes and water cross TJs through 2 distinct pathways based on their size and charge selectivity: the pore pathway48, 49, 50 and the leak pathway.48,51”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [48] Zuo, 2020, Tight junctions as targets and effectors of mucosal immune homeostasis, Cell Mol Gastroenterol Hepatol source
Not checked in the free run.
- cites [49] Turner, 2009, Intestinal mucosal barrier function in health and disease, Nat Rev Immunol source
Not checked in the free run.
- cites [50] Anderson, 2009, Physiology and function of the tight junction, Cold Spring Harb Perspect Biol source
Not checked in the free run.
- cites [51] Buschmann, 2013, Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux, Mol Biol Cell source
Not checked in the free run.
- Premisecitation
Upregulated IL-13 and Cldn-2 induce epithelial apoptosis, resulting in epithelial barrier disruption.
“Upregulated IL-13 and Cldn-2 induce epithelial apoptosis, resulting in epithelial barrier disruption.58”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [58] Heller, 2008, Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell function, Mucosal Immunol source
Not checked in the free run.
- Interpretationnone given
The mechanisms of action of gut microbial metabolites mainly point to a small group of shared pathways that control gut barrier functions.
“While the mechanisms of action of these metabolites are only beginning to emerge, they mainly point to a small group of shared pathways that control gut barrier functions.”
Quote in the paperNot a substantial claim - Premisecitation
AhR-/- mice exhibit increased inflammation and severe colitis phenotypes compared with wild type mice in the TNBS- or DSS-induced colitis models.
“AhR–/– mice exhibit increased inflammation and severe colitis phenotypes compared with wild type mice in the 2,4,6-trinitrobenzene sulfonic acid (TNBS) or DSS-induced colitis models.22,96”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [22] Singh, 2019, Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway, Nat Commun source
Not checked in the free run.
- cites [96] Shao, 2018, Intestinal HIF-1alpha deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction, J Hepatol source
Not checked in the free run.
- Premisecitation
Sodium butyrate at a concentration ranging between 1 and 10 mM significantly improved epithelial barrier function in E12 human colon cells by increasing the levels of mucin 2.
“It was shown that sodium butyrate at a concentration ranging between 1 and 10 mM significantly improved epithelial barrier function in E12 human colon cells by increasing the levels of mucin 2 (MUC2).79”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [79] Nielsen, 2018, Effect of butyrate and fermentation products on epithelial integrity in a mucus-secreting human colon cell line, Journal of Functional Foods source
Not checked in the free run.
- Premisecitation
Consumption of diets enriched in SCFA and butyrate production by human subjects with metabolic syndrome exhibited increased colonic expression of MUC2 and OCLN, suggesting beneficial action of butyrate in gut barrier function.
“Importantly, consumption of diets enriched in SCFA and butyrate production by human subjects with metabolic syndrome exhibited increased colonic expression of MUC2 and OCLN, suggesting beneficial action of butyrate in gut barrier function.86”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [86] Hald, 2015
Not checked in the free run.
- Premisecitation
Indole levels in fecal samples of germ-free mice were 27-fold lower compared with conventionally raised mice.
“It was reported that indole levels in fecal samples of germ-free (GF) mice were 27-fold lower compared with conventionally raised mice.90”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [90] Shimada, 2013, Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon, PLoS One source
Not checked in the free run.
- Premisecitation
An impaired capacity of gut microbiota to metabolize tryptophan into multiple AhR agonists has been associated with metabolic syndrome in humans and mice.
“An impaired capacity of gut microbiota to metabolize tryptophan into multiple AhR agonists has been associated with metabolic syndrome in humans and mice.95”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [95] Natividad, 2018, Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome, Cell Metab source
Not checked in the free run.
- Premisenone given
Dietary tryptophan is catabolized into indole by tryptophanase expressed by several microbes such as indole-positive Clostridium sporogenes.
“Dietary tryptophan is catabolized into indole by tryptophanase expressed by several microbes such as indole-positive Clostridium sporogenes.”
Quote in the paperSubstantial claim - Premisecitation
Supplementation with both Lactobacillus strains and synthetic AhR agonists ameliorated intestinal inflammation in IBD patients.
“Supplementation with both Lactobacillus strains and synthetic AhR agonists ameliorated intestinal inflammation in IBD patients.101”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [101] Russo, 2019, Immunomodulating activity and therapeutic effects of short chain fatty acids and tryptophan post-biotics in inflammatory bowel disease, Front Immunol source
Not checked in the free run.
- Premisecitation
Treatment with SCFA such as acetate, propionate, and butyrate induced expression of tight junction proteins of intestinal epithelial cells.
“Furthermore, Feng et al83 reported that treatment with SCFA such as acetate, propionate, and butyrate induced expression of TJ proteins of IECs.83”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [83] Feng, 2018, Short-chain fatty acids manifest stimulative and protective effects on intestinal barrier function through the inhibition of NLRP3 inflammasome and autophagy, Cell Physiol Biochem source
Not checked in the free run.
- Premisecitation
Activation of AhR by tryptophan ligands such as FICZ enhances gut barrier function.
“Activation of AhR by tryptophan ligands such as 6-formylindolo(3,2-b) carbazole (FICZ) enhances gut barrier function.”
Quote in the paperSubstantial claim - Premisecitation
Supplementation of indole capsules restored gut barrier integrity by elevating junctional protein expression in germ-free mice.
“Importantly, supplementation of indole capsules restored gut barrier integrity by elevating junctional protein expression in GF mice.90”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [90] Shimada, 2013, Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon, PLoS One source
Not checked in the free run.
- Premisecitation
Tight junction and adherens junction proteins (Cldn7, Ocln, ZO-1, E-cadherin 1) are significantly decreased in germ-free mice compared with conventionally raised mice.
“TJ and AJ proteins (Cldn7, Ocln, ZO-1, E-cadherin 1) are significantly decreased in GF mice compared with conventionally raised mice.90”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [90] Shimada, 2013, Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon, PLoS One source
Not checked in the free run.
- Premisecitation
Treatment with sodium butyrate led to the upregulation of CLDN-1 transcription by increasing the interaction between the motif specific promoter region of CLDN-1 and transcription factor SP1.
“Treatment with sodium butyrate led to the upregulation of CLDN-1 transcription by increasing the interaction between the motif specific promoter region of CLDN-1 and transcription factor SP1.82”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [82] Wang, 2012, Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein claudin-1 transcription, Dig Dis Sci source
Not checked in the free run.
- Premisecitation
Dietary supplementation with synthetic AhR agonists or bacterial strains that naturally produce AhR ligands by tryptophan metabolism enhanced gut barrier function via secretion of incretin hormone glucagon-like peptide-1.
“Dietary supplementation with synthetic AhR agonists or bacterial strains that naturally produce AhR ligands by Tryptophan metabolism enhanced gut barrier function via secretion of incretin hormone glucagon-like peptide-1.95”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [95] Natividad, 2018, Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome, Cell Metab source
Not checked in the free run.
- Premisecitation
Low levels of naturally occurring AhR ligands were reported in IBD patients.
“In parallel to these observations in mice, low levels of naturally occurring AhR ligands were reported in IBD patients.100”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [100] Metidji, 2019, The environmental sensor AHR protects from inflammatory damage by maintaining intestinal stem cell homeostasis and barrier integrity, Immunity source
Not checked in the free run.
- Premisecitation
FICZ prevented a TNF-α/interferon gamma-induced decrease in transepithelial electrical resistance and disruption of tight junction proteins in Caco-2 monolayers.
“In addition, FICZ also prevented a TNF-α/interferon gamma–induced decrease in transepithelial electrical resistance (TEER) and disruption of TJ proteins in Caco-2 monolayers.92”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [92] Yu, 2018, Aryl hydrocarbon receptor activation modulates intestinal epithelial barrier function by maintaining tight junction integrity, Int J Biol Sci source
Not checked in the free run.
- Premisecitation
Butyrate induces activation of AMPK that protects intestinal barrier integrity by facilitating the assembly of tight junction proteins.
“It was shown that butyrate induces activation of AMPK (AMP-activated protein kinase) that protects intestinal barrier integrity by facilitating the assembly of TJ proteins.81”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [81] Peng, 2009, Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers, J Nutr
Not checked in the free run.
- Premisenone given
Tryptophan microbial metabolites are well-known ligands for the aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor that senses environmental toxins and endogenous ligands.
“Tryptophan microbial metabolites are also well-known ligands for the aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor that senses environmental toxins and endogenous ligands.”
Quote in the paperSubstantial claim - Premisenone given
The G protein-coupled bile acid receptor GP-BAR1 (also called TGR5) is highly expressed in the ileum and colon.
“The G protein–coupled bile acid receptor (GP-BAR1) (also called as TGR5) is highly expressed in the ileum and colon.”
Quote in the paperSubstantial claim - Premisecitation
DCA and CDCA modulated intestinal permeability via endothelial growth factor receptor autophosphorylation, OCLN dephosphorylation, and rearrangement at the tight junction level.
“This study concluded that DCA and CDCA modulated intestinal permeability via endothelial growth factor (EGF) receptor autophosphorylation, OCLN dephosphorylation, and rearrangement at the TJ level.110”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [110] Raimondi, 2008, Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation, Am J Physiol Gastrointest Liver Physiol source
Not checked in the free run.
- Interpretationcitation
Targeted interventions can improve bile acid-FXR-fibroblast growth factor 15 signaling by modulation of hepatic Cyp7a1 and lipid metabolism, thereby reducing ethanol-induced liver disease in mice.
“These studies suggested that targeted interventions can improve bile acid-FXR-fibroblast growth factor 15 signaling by modulation of hepatic Cyp7a1 and lipid metabolism, thereby reducing ethanol-induced liver disease in mice.116”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [116] Hartmann, 2018, Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice, Hepatology source
Not checked in the free run.
- Premisecitation
Mice treated with GP-BAR1 agonists (ciprofloxacin and oleanolic acid) abrogated the signs and symptoms of TNBS-induced colitis.
“Mice treated with GP-BAR1 agonists (ciprofloxacin and oleanolic acid) abrogated the signs and symptoms of TNBS-induced colitis.117”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [117] Cipriani, 2011, The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis, PLoS One source
Not checked in the free run.
- Premisecitation
Secondary bile acids antagonize the nuclear membrane farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5 in the intestines.
“Secondary bile acids antagonize the nuclear membrane farnesoid X receptor (FXR) and the G protein–coupled receptor TGR5103 in the intestines.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [103] Li, 2014, Bile acid signaling in metabolic disease and drug therapy, Pharmacol Rev source
Not checked in the free run.
- Premisecitation
The primary bile acid CDCA and its 7α-dehydroxylated derivative LCA have opposite effects on epithelial integrity in human colonic T84 cells.
“For example, it was shown that the primary bile acid CDCA and its 7α-dehydroxylated derivative LCA have opposite effects on epithelial integrity in human colonic T84 cells.”
Quote in the paperNot a substantial claim - Premisecitation
Mice fed a diet containing DCA exhibited increased gut permeability (>1.5-fold) compared with mice fed a regular diet.
“Mice fed a diet containing DCA exhibited increased gut permeability (>1.5-fold) compared with mice fed a regular diet.”
Quote in the paperSubstantial claim - Premisecitation
Alcoholic liver disease is associated with gut microbial dysbiosis.
“Alcoholic liver disease (ALD) is associated with gut microbial dysbiosis,113, 114, 115”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [113] Maccioni, 2020, Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans, Gut Microbes source
Not checked in the free run.
- cites [114] Meroni, 2019, Alcohol or gut microbiota: who is the guilty?, Int J Mol Sci source
Not checked in the free run.
- cites [115] Cassard, 2018, Microbiota, a key player in alcoholic liver disease, Clin Mol Hepatol source
Not checked in the free run.
- Premisecitation
Intestinal bacteria such as Bifidobacterium, Butyrivibrio, Enterobacter, Lactobacillus, Clostridium, Citrobacter, Roseburia, Klebsiella, and Megasphaera can produce conjugated fatty acid metabolites from fat-enriched diets.
“Intestinal bacteria such as Bifidobacterium, Butyrivibrio, Enterobacter, Lactobacillus, Clostridium, Citrobacter, Roseburia, Klebsiella, and Megasphaera can produce conjugated fatty acid metabolites from fat-enriched diets.118”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [118] Schoeler, 2019, Dietary lipids, gut microbiota and lipid metabolism, Rev Endocr Metab Disord source
Not checked in the free run.
- Premisecitation
CLA treatment significantly increased the expression of the TJ proteins ZO-1, OCLN, and CLDN-3 in the DSS-induced colitis mouse model.
“Additionally, treatment with CLA significantly increased the expression of the TJ proteins ZO-1, OCLN, and CLDN-3 in the DSS-induced colitis mouse model.120”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] Chen, 2019, Orally administered CLA ameliorates DSS-induced colitis in mice via intestinal barrier improvement, oxidative stress reduction, and inflammatory cytokine and gut microbiota modulation, J Agric Food Chem source
Not checked in the free run.
- Premisecitation
High fat diet-induced impairment of gut barrier function is associated with the proportion of UDCA vs DCA.
“It was shown that high fat diet-induced impairment of gut barrier function is associated with the proportion of UDCA vs DCA.105,107”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [105] Stenman, 2012, High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids, World J Gastroenterol source
Not checked in the free run.
- cites [107] Stenman, 2013, A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids, Am J Physiol Gastrointest Liver Physiol source
Not checked in the free run.
- Premisecitation
A study on prematurely weaned piglets reported that administration of CDCA improves gut barrier protection by inducing expression of ZO-1 and reducing expression of TNF-α, IL-6, and IL-10.
“A study on prematurely weaned piglets reported that administration of CDCA improves the gut barrier protection by inducing expression of ZO-1 and reducing expression of TNF-α, IL-6, and IL-10.111”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [111] de Diego-Cabero, 2015, Bile acid mediated effects on gut integrity and performance of early weaned piglets, BMC Vet Res source
Not checked in the free run.
- Premisecitation
ALD-associated microbiota changes lead to alterations in bile acid profiles, including increased amounts of unconjugated bile acids in the small intestine.
“and ALD-associated microbiota changes lead to alterations in bile acid profiles (ie, increased amounts of unconjugated bile acids in the small intestine).116”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [116] Hartmann, 2018, Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice, Hepatology source
Not checked in the free run.
- Premisecitation
GP-BAR1-/- mice were more susceptible to DSS- or TNBS-induced colitis.
“Importantly these mice were more susceptible to DSS- or TNBS-induced colitis.117”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [117] Cipriani, 2011, The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis, PLoS One source
Not checked in the free run.
- Premisecitation
Dietary supplementation of CLA ameliorated DSS-induced colitis in mice.
“Dietary supplementation of CLA ameliorated DSS-induced colitis in mice.120”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] Chen, 2019, Orally administered CLA ameliorates DSS-induced colitis in mice via intestinal barrier improvement, oxidative stress reduction, and inflammatory cytokine and gut microbiota modulation, J Agric Food Chem source
Not checked in the free run.
- Premisecitation
Numerous bacterial products regulate gut barrier function by activating Toll-like receptors (TLR) and nucleotide-binding and oligomerization domain (NOD)-like receptor (NLR) pathways.
“Numerous bacterial products regulate gut barrier function by activating Toll-like receptors (TLR) and nucleotide-binding and oligomerization domain (NOD)-like receptor (NLR) pathways.153, 154, 155, 156”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [153] Ong, 2017, Microbial factors in inflammatory diseases and cancers, Adv Exp Med Biol source
Not checked in the free run.
- cites [154] Mu, 2015, Crosstalk between the immune receptors and gut microbiota, Curr Protein Pept Sci source
Not checked in the free run.
- cites [155] Marques, 2011, Expression and functional importance of innate immune receptors by intestinal epithelial cells, Cell Mol Life Sci source
Not checked in the free run.
- Premisecitation
B. pseudocatenulatum strain INIA P815 is responsible for the production of UroA and UroB by metabolizing EA.
“Recently, B. pseudocatenulatum strain INIA P815 was shown to be responsible for the production of UroA and UroB by metabolizing EA.147”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [147] Gaya, 2018, Bifidobacterium pseudocatenulatum INIA P815: The first bacterium abl e to produce urolithins A and B from ellagic acid, J Funct Foods source
Not checked in the free run.
- Premisecitation
Polyamines enhance gut barrier integrity through inducing E-cadherin, the cell-cell adhesion protein, in a c-Myc-dependent manner.
“Polyamines enhance gut barrier integrity through inducing E-cadherin, the cell-cell adhesion protein in c-Myc–dependent manner.126”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [126] Liu, 2009, Polyamines regulate E-cadherin transcription through c-Myc modulating intestinal epithelial barrier function, Am J Physiol Cell Physiol source
Not checked in the free run.
- Premisecitation
Compared with ETs or EA, urolithins have a much higher rate of absorption most likely due to increased lipophilicity.
“Compared with ETs or EA, urolithins have a much higher rate of absorption most likely due to increased lipophilicity.132”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [132] Espin, 2007, Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans, J Agric Food Chem source
Not checked in the free run.
- Premisecitation
Gut microbes such as E. coli, Bacteroides spp. and Fusobacterium spp. can synthesize polyamines.
“Gut microbes such as E. coli, Bacteroides spp. and Fusobacterium spp. can synthesize polyamines.122”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [122] Tofalo, 2019, Polyamines and gut microbiota, Front Nutr source
Not checked in the free run.
- Premisecitation
UroA can only be detected in ∼40%-50% of human subjects upon consumption of EA/ET-containing diets.
“However, UroA can only be detected in ∼ 40%–50% of human subjects upon consumption of EA/ET-containing diets.131,136, 137, 138, 139, 140, 141, 142, 143”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [131] Cerda, 2005, Identification of urolithin a as a metabolite produced by human colon microflora from ellagic acid and related compounds, J Agric Food Chem source
Not checked in the free run.
- cites [136] Cerda, 2004, The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans, Eur J Nutr source
Not checked in the free run.
- cites [137] Garcia-Villalba, 2013, Time course production of urolithins from ellagic acid by human gut microbiota, J Agric Food Chem source
Not checked in the free run.
- Premisecitation
Anthocyanins and proanthocyanidins from blueberries ameliorated E. coli-induced gut barrier dysfunction.
“Moreover, anthocyanins and proanthocyanidins, polyphenols form blueberries, ameliorated E. coli–induced gut barrier dysfunction.152”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [152] Polewski, 2020, Isolation and characterization of blueberry polyphenolic components and their effects on gut barrier dysfunction, J Agric Food Chem source
Not checked in the free run.
- Premisecitation
Upon consumption of 1L of pomegranate juice daily for 5 days by healthy volunteers, urolithin levels ranged from 0.5 to 18.6 μM in the plasma.
“For example, upon consumption of 1L of pomegranate juice daily for 5 days by healthy volunteers, urolithin levels ranged from 0.5 to 18.6 μM in the plasma.136”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [136] Cerda, 2004, The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans, Eur J Nutr source
Not checked in the free run.
- Premisecitation
UroA failed to upregulate TJ proteins such as Cldn4, ZO-1 and Ocln in AhR-/- and Nrf2-/- mice.
“UroA failed to upregulate TJ proteins such as Cldn4, ZO-1 and Ocln in AhR–/– and Nrf2–/– mice.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] Singh, 2019, Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway, Nat Commun source
Not checked in the free run.
- Premisecitation
Lignan derived microbial metabolites such as equol and enterolactone protected against nitric oxide-, TNF-α-, and IL-6-induced barrier dysfunction.
“Lignan derived microbial metabolites such as equol and enterolactone protected against nitric oxide–, TNF-α–, and IL-6–induced barrier dysfunction.151”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [151] Johnson, 2019, Polyphenol microbial metabolites exhibit gut and blood(-)brain barrier permeability and protect murine microglia against LPS-induced inflammation, Metabolites source
Not checked in the free run.
- Premisecitation
Dietary ellagic acid derivatives such as ellagitannins are metabolized into various bioactive metabolites including urolithins by human gut microflora.
“For example, dietary ellagic acid (EA) derivatives such as ellagitannins (ETs) are metabolized into various bioactive metabolites including urolithins (Urolithin A, B, C, D, and iso-urolithin A) by human gut microflora.129”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [129] Heber, 2008, Multitargeted therapy of cancer by ellagitannins, Cancer LEtt source
Not checked in the free run.
- Premisecitation
Gordonibacter urolithinfaciens sp. nov. and G. pamelaeae DSM 19378(T) convert EA to Urolithin M-5, M-6 and C.
“It was reported that 2 species of human intestinal bacteria, Gordonibacter urolithinfaciens, sp. nov. and G. pamelaeae DSM 19378(T), convert EA to Urolithin M-5, M-6 and C.146”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [146] Selma, 2014, Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species, Food Funct source
Not checked in the free run.
- Premisenone given
Polyamine depletion does not alter expression of TJ proteins such as ZO-1, ZO-2, and junctional adhesion molecule-1.
“Interestingly, polyamine depletion does not alter expression of TJ proteins such as ZO-1, ZO-2, and junctional adhesion molecule-1.”
Quote in the paperSubstantial claim - Premisecitation
Treatment with UroA significantly enhanced gut barrier integrity through upregulation of TJ proteins via an AhR-Nrf2-dependent pathway.
“Our group demonstrated that treatment with UroA significantly enhanced gut barrier integrity through upregulation of TJ proteins via an AhR-Nrf2–dependent pathway.22”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] Singh, 2019, Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway, Nat Commun source
Not checked in the free run.
- Premisecitation
The concentration of serum urolithins can reach up to micromolar levels without displaying toxicity in certain populations.
“The concentration of serum urolithins can reach up to micromolar levels without displaying toxicity in certain populations.132,134,138,144,145”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [132] Espin, 2007, Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans, J Agric Food Chem source
Not checked in the free run.
- cites [134] Ryu, 2016, Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents, Nat Med source
Not checked in the free run.
- cites [138] Gonzalez-Sarrias, 2010, Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice, Mol Nutr Food Res source
Not checked in the free run.
- Interpretationcitation
Polyamines regulate gut barrier function through upregulating E-cadherin in an intracellular Ca2+-dependent manner.
“These studies suggested that polyamines regulate gut barrier function through upregulating E-cadherin in an intracellular Ca2+-dependent manner.127”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [127] Guo, 2003, Regulation of adherens junctions and epithelial paracellular permeability: a novel function for polyamines, Am J Physiol Cell Physiol source
Not checked in the free run.
- Premisecitation
The health benefits of consumption of pomegranate and pomegranate juice are attributed to the activities of urolithins.
“The health benefits of consumption of pomegranate and pomegranate juice are attributed to the activities of these urolithins.130,131”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [130] Espin, 2013, Biological significance of urolithins, the gut microbial ellagic Acid-derived metabolites: the evidence so far, Evid Based Complement Alternat Med source
Not checked in the free run.
- cites [131] Cerda, 2005, Identification of urolithin a as a metabolite produced by human colon microflora from ellagic acid and related compounds, J Agric Food Chem source
Not checked in the free run.
- Premisenone given
Microbial metabolites regulate host immunity by exploiting metabolite-specific immune cell receptors such as AhR, FXR, pregnane X receptor, membrane bile acid receptor (M-BAR/TGR5), purinergic receptor (P2X7), and G protein-coupled receptors (GPR41, GPR43, GPR109A).
“As discussed previously, microbial metabolites regulate host immunity by exploiting metabolite-specific immune cell receptors such as AhR, FXR, pregnane X receptor, membrane bile acid receptor (M-BAR/TGR5), purinergic receptor (P2X7), and G protein–coupled receptors (GPR41, GPR43, GPR109A).”
Quote in the paperNot a substantial claim - Interpretationreasoning
TLR4 plays an important role in modulating gut barrier function.
“Overall, these studies suggest that TLR4 plays an important role in modulating gut barrier function.”
Quote in the paperSubstantial claim - Premisecitation
Blocking LPS-mediated signaling protects against gut barrier disruption.
“Blocking LPS-mediated signaling has been shown to protect against gut barrier disruption.”
Quote in the paperSubstantial claim - Premisecitation
TLR4-/- mice exhibited less intestinal permeability compared with wild type mice in a burn injury model due to unaltered expression of the TJ protein OCLN.
“TLR4–/– mice exhibited less intestinal permeability (FITC-dextran permeability assay) compared with wild type mice in a burn injury model due to unaltered expression of the TJ protein OCLN.163”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [163] Peterson, 2010, Toll-like receptor-4 mediates intestinal barrier breakdown after thermal injury, Surg Infect (Larchmt) source
Not checked in the free run.
- Premisecitation
Treatment with the TLR2 agonist Pam3CSK4 increased gap junctional intercellular communication through connexin-43 during IEC injury.
“It was shown that the treatment with the TLR2 agonist Pam3CSK4 (PCSK [proprotein convertase subtilisin/kexin]) increased the gap junctional intercellular communication through connexin-43 during IEC injury.158”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [158] Ey, 2009, TLR2 mediates gap junctional intercellular communication through connexin-43 in intestinal epithelial barrier injury, J Biol Chem source
Not checked in the free run.
- Premisecitation
The mucosal immune system profoundly impacts gut barrier functions both in health and disease conditions.
“Additionally, the mucosal immune system profoundly impacts gut barrier functions both in health and disease conditions, reviewed previously.48,179, 180, 181, 182, 183”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [48] Zuo, 2020, Tight junctions as targets and effectors of mucosal immune homeostasis, Cell Mol Gastroenterol Hepatol source
Not checked in the free run.
- cites [179] Arpaia, 2013, Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation, Nature source
Not checked in the free run.
- cites [180] Konieczna, 2013, Immunomodulation by Bifidobacterium infantis 35624 in the murine lamina propria requires retinoic acid-dependent and independent mechanisms, PLoS One source
Not checked in the free run.
- Premisenone given
Bacterial LPS mediates proinflammatory signaling through TLR4 and the adapter molecule MyD88.
“Bacterial LPS mediates proinflammatory signaling through TLR4 and the adapter molecule MyD88.”
Quote in the paperSubstantial claim - Premisecitation
TLR5-/- mice developed spontaneous colitis due to increased bacterial burdens and reduced anti-inflammatory cytokine secretion.
“Further, TLR5–/– mice developed spontaneous colitis due to increased bacterial burdens and reduced anti-inflammatory cytokine secretion.166,170”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [166] Vijay-Kumar, 2007, Deletion of TLR5 results in spontaneous colitis in mice, J Clin Invest
Not checked in the free run.
- cites [170] Carvalho, 2011, TLR5 activation induces secretory interleukin-1 receptor antagonist (sIL-1Ra) and reduces inflammasome-associated tissue damage, Mucosal Immunol source
Not checked in the free run.
- Premisecitation
The TLR4/NF-κB signaling pathway may be critical to the mechanism underlying hypoxia-induced damage to intestinal barrier function and bacterial translocation.
“It was also shown that the TLR4/NF-κB signaling pathway may be critical to the mechanism underlying hypoxia-induced damage to intestinal barrier function and bacterial translocation.161”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [161] Luo, 2012, Role of TLR4/NF-kappaB in damage to intestinal mucosa barrier function and bacterial translocation in rats exposed to hypoxia, PLoS One source
Not checked in the free run.
- Premisecitation
Oral treatment with the TLR2 ligand PCSK significantly suppressed mucosal inflammation and apoptosis by efficiently restoring TJ-associated integrity of the intestinal epithelium in a mouse colitis model.
“In this study, the authors showed that oral treatment with the TLR2 ligand, PCSK significantly suppressed mucosal inflammation and apoptosis by efficiently restoring TJ-associated integrity of the intestinal epithelium in a mouse colitis model.159”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [159] Cario, 2007, Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function, Gastroenterology source
Not checked in the free run.
- Premisecitation
TLR2 stimulation effectively preserves TJ-associated barrier assembly against stress-induced damage through promotion of PI3K/Akt-mediated cell survival in an MyD88-dependent manner.
“Furthermore, Cario et al159 demonstrated using both in vitro and ex vivo models that TLR2 stimulation effectively preserves TJ-associated barrier assembly against stress-induced damage through promotion of PI3K/Akt-mediated cell survival in an MyD88-dependent manner.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [159] Cario, 2007, Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function, Gastroenterology source
Not checked in the free run.
- Interpretationreasoning
Bacterial structural components either directly or indirectly impact and modulate the gut barrier functions both in health and disease conditions.
“In summary, bacterial structural components either directly or indirectly (through increasing inflammatory mediators and regulating immune system) impact and modulate the gut barrier functions both in health and disease conditions.”
Quote in the paperSubstantial claim - Premisecitation
Wogonin suppresses the inflammatory response and maintains intestinal barrier function via the TLR4-MyD88-TAK1-NF-κB pathway in Caco-2 cells.
“For example, wogonin suppresses the inflammatory response and maintains intestinal barrier function via the TLR4-MyD88-TAK1 (TGF-β activated kinase 1)-NF-κB (nuclear factor-kappa B) pathway in Caco-2 cells.160”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [160] Wang, 2015, Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-kappaB pathway in vitro, Inflamm Res source
Not checked in the free run.
- Premisecitation
Treatment with the TLR4 antagonist CRX-526 inhibited the development of disease in an acute DSS colitis model.
“Importantly, treatment with a TLR4 antagonist (CRX-526) inhibited the development of disease in an acute DSS colitis model.108”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [108] Fort, 2005, A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease, J Immunol source
Not checked in the free run.
- Premisecitation
Genetic deletion of sEH (sEH knockout mice) abolished obesity-induced gut leakage, endotoxin lipopolysaccharide and bacterial translocation.
“Further, genetic deletion of sEH (sEH knockout mice) abolished obesity-induced gut leakage, endotoxin lipopolysaccharide and bacterial translocation.199”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [199] Wang, 2020, Soluble epoxide hydrolase is an endogenous regulator of obesity-induced intestinal barrier dysfunction and bacterial translocation, Proc Natl Acad Sci U S A source
Not checked in the free run.
- Premisecitation
UroA and its synthetic structural analogue UAS03 enhanced gut barrier function via upregulation of TJ proteins such as CLDN-4, OCLN, and ZO-1.
“Our group showed that UroA and its synthetic structural analogue UAS03 enhanced gut barrier function via upregulation of TJ proteins such as CLDN-4, OCLN, and ZO-1.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] Singh, 2019, Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway, Nat Commun source
Not checked in the free run.
- Premisecitation
Increased expression of sEH led to enhanced gut permeability in diet-induced obesity models.
“It was demonstrated that increased expression of sEH led to enhanced gut permeability in diet-induced obesity models.199”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [199] Wang, 2020, Soluble epoxide hydrolase is an endogenous regulator of obesity-induced intestinal barrier dysfunction and bacterial translocation, Proc Natl Acad Sci U S A source
Not checked in the free run.
- Premisecitation
Implantation with IL-10 producing Lactococcus lactis reduced inflammation in a mouse colitis disease model.
“Similarly, implantation with IL-10 producing Lactococcus lactis reduced inflammation in a mouse colitis disease model.193,194”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [193] Braat, 2006, A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease, Clin Gastroenterol Hepatol source
Not checked in the free run.
- cites [194] Steidler, 2000, Treatment of murine colitis by Lactococcus lactis secreting interleukin-10, Science source
Not checked in the free run.
- Premisecitation
Activated Drp1 led to distribution of ZO1 protein and increased intestinal permeability in a ROS-specific manner.
“It was shown that activated Drp1 led to distribution of ZO1 protein and increased intestinal permeability in a ROS-specific manner.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [198] Duan, 2020, Activated Drp1-mediated mitochondrial ROS influence the gut microbiome and intestinal barrier after hemorrhagic shock, Aging (Albany NY) source
Not checked in the free run.
- Premisecitation
Treatment with divertin regulates paracellular transport rather than transcellular transport across the membranes.
“Importantly, they provided the evidence that treatment with divertin regulate paracellular transport rather than transcellular transport across the membranes.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [191] Graham, 2019, Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis, Nat Med source
Not checked in the free run.
- Premisecitation
Pharmacological inhibition of sEH prevented obesity-induced gut barrier dysfunction.
“Pharmacological inhibition of sEH (trans-4-(4-[3-(4-trifluoromethoxyphenyl) ureido] cyclohexyloxy) benzoic acid (t-TUCB), prevented obesity-induced gut barrier dysfunction suggesting sEH inhibitors may be promising agents for gut barrier dysfunction treatment in obesity conditions.199”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [199] Wang, 2020, Soluble epoxide hydrolase is an endogenous regulator of obesity-induced intestinal barrier dysfunction and bacterial translocation, Proc Natl Acad Sci U S A source
Not checked in the free run.
- Premisecitation
Withdrawal of treatment in some cases can reverse gut barrier dysfunction.
“Hence, withdrawal of treatment in some cases can also reverse gut barrier dysfunction.206”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [206] Piton, 2016, Biomarkers of gut barrier failure in the ICU, Curr Opin Crit Care
Not checked in the free run.
- Premisecitation
Supplementation of dietary garcinol inhibited intestinal barrier dysfunction via elevated ZO-1, CLDN-1, and OCLN expression.
“Supplementation of dietary garcinol inhibited intestinal barrier dysfunction via elevated ZO-1, CLDN-1, and OCLN expression.204”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [204] Wang, 2020, Dietary garcinol supplementation improves diarrhea and intestinal barrier function associated with its modulation of gut microbiota in weaned piglets, J Anim Sci Biotechnol source
Not checked in the free run.
- Premisecitation
Blocking Drp1-induced ROS accumulation by N-acetylcysteine in IECs protected TJs and improved intestinal barrier function after hypoxia.
“Further, blocking Drp1-induced ROS accumulation by N-acetylcysteine in IECs protected TJs and improved intestinal barrier function after hypoxia.198”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [198] Duan, 2020, Activated Drp1-mediated mitochondrial ROS influence the gut microbiome and intestinal barrier after hemorrhagic shock, Aging (Albany NY) source
Not checked in the free run.
- Premisecitation
Microbial manipulations and supplementation of microbial metabolites are being considered as emerging preventive and therapeutic medicines for numerous disorders including those with gut barrier dysfunction and dysbiosis.
“Microbial manipulations and supplementation of microbial metabolites are being considered as emerging preventive and therapeutic medicines for numerous disorders185, 186, 187 including those with gut barrier dysfunction and dysbiosis.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [185] Ahern, 2014, Mining the human gut microbiota for effector strains that shape the immune system, Immunity source
Not checked in the free run.
- cites [186] Duan, 2015, Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes, Diabetes source
Not checked in the free run.
- cites [187] Duan, 2008, Secretion of insulinotropic proteins by commensal bacteria: rewiring the gut to treat diabetes, Appl Environ Microbiol source
Not checked in the free run.
- Premisecitation
Treatment with divertin blocked acute interferon gamma-primed TNF-induced MLC phosphorylation and barrier loss in Caco-2 monolayers model system.
“Further, they showed that treatment with divertin blocked acute interferon gamma–primed TNF-induced MLC phosphorylation and barrier loss in Caco-2 monolayers model system.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [191] Graham, 2019, Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis, Nat Med source
Not checked in the free run.
- Premisecitation
A domain binding small molecule called "divertin" blocks the recruitment of MLCK1 without inhibiting enzyme function.
“It was shown by the Turner group that a domain binding small molecule called “divertin” blocks the recruitment of MLCK1 without inhibiting enzyme function.191”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [191] Graham, 2019, Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis, Nat Med source
Not checked in the free run.
- Premisecitation
Treatment with divertin reduced the progression and severity of experimental chronic colitis of T cell transfer model by correcting gut permeability.
“Treatment with divertin also reduced the progression and severity of experimental chronic colitis of T cell transfer model (CD4+ effector T cells in immunodeficient mice) by correcting gut permeability.191”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [191] Graham, 2019, Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis, Nat Med source
Not checked in the free run.
- Premisecitation
Activation of mitochondrial dynamin-related protein (Drp1) regulates gut barrier function through regulating SCFA-producing gut microbiota in hemorrhagic shock mouse models.
“Activation of mitochondrial dynamin-related protein (Drp1) regulates gut barrier function through regulating SCFA-producing gut microbiota in hemorrhagic shock mouse models.198”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [198] Duan, 2020, Activated Drp1-mediated mitochondrial ROS influence the gut microbiome and intestinal barrier after hemorrhagic shock, Aging (Albany NY) source
Not checked in the free run.
- Premisecitation
Soluble epoxide hydrolase (sEH) and its metabolites (as dihydroxyeicosatrienoic acids) were upregulated in the colon tissues of diet-induced obese mice.
“Studies have shown that soluble epoxide hydrolase (sEH) and its metabolites (as dihydroxyeicosatrienoic acids) were upregulated in the colon tissues of diet-induced obese mice.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [199] Wang, 2020, Soluble epoxide hydrolase is an endogenous regulator of obesity-induced intestinal barrier dysfunction and bacterial translocation, Proc Natl Acad Sci U S A source
Not checked in the free run.
- Premisecitation
Astragaloside IV induced TJ protein expression by suppressing RhoA/NLRP3 inflammasome signaling pathways in a sepsis model.
“It was shown that a bioactive compound from Astragalus membranaceus, Astragaloside IV (AS-IV) induced TJ protein expression by suppressing RhoA/NLRP3 inflammasome signaling pathways in a sepsis model.197”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [197] Li, 2020, Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-kappaB pathway, Pharmacol Res source
Not checked in the free run.
- Premisecitation
Irisin ameliorated gut barrier dysfunction via activation of the AMPK-UCP 2 pathway and binding to the integrin αVβ5 receptor.
“Irisin, a newly identified exercise hormone, was also reported to ameliorate gut barrier dysfunction via activation of the AMPK-UCP 2 pathway and binding to the integrin αVβ5 receptor.202”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [202] Bi, 2020, Irisin reverses intestinal epithelial barrier dysfunction during intestinal injury via binding to the integrin alphaVbeta5 receptor, J Cell Mol Med source
Not checked in the free run.
- Classified as probably not a substantial claim. 18
- May combine two claims. 73
- The quote only partly states this claim. 1
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEnterocytes connect with each other in a continuous epithelial cell layer via adhesive junctional proteins that make up tight junction proteins, adherens junction proteins, gap junction proteins, and desmosomes.
“Enterocytes connect with each other in a continuous epithelial cell layer via adhesive junctional proteins that make up tight junction (TJ) proteins, adherens junction (AJ) proteins, gap junction proteins, and desmosomes (Table 2).31,32”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [31] Niessen, 2007, Tight junctions/adherens junctions: basic structure and function, J Invest Dermatol source
Not checked in the free run.
- cites [32] Groschwitz, 2009, Intestinal barrier function: molecular regulation and disease pathogenesis, J Allergy Clin Immunol source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenIncreased gut barrier permeability occurs through dysregulation of epithelial apoptosis/enterocyte death, mucus degradation, and increased paracellular permeability due to disruption of tight junctions.
“Increased gut barrier permeability occurs through dysregulation of epithelial apoptosis/enterocyte death, mucus degradation, and increased paracellular permeability due to disruption of TJs.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTNF-α induced loss of epithelial integrity due to apoptosis accounted for about 56% of the damage, and the rest was by disruption of tight junctions in nonapoptotic areas.
“TNF-α induced loss of the epithelial integrity due to apoptosis accounted for about 56% of the damage and the rest was by disruption of TJs in nonapoptotic areas.57”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Gitter, 2000, Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis, FASEB J source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHumans and microbes have coevolved over millions of years, contributing to the interdependency of host and microbiota physiological activities.
“Humans and microbes have coevolved over millions of years, thereby contributing to the interdependency of host and microbiota physiological activities.1”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] Li, 2008, Symbiotic gut microbes modulate human metabolic phenotypes, Proc Natl Acad Sci U S A source
Not checked in the free run.
May combine two claims.
PremisecitationTNF-α disrupts the gut barrier not only by degradation in tight junctions, but also through the induction of epithelial apoptosis.
“For example, Gitter et al57 showed that tumor necrosis factor alpha (TNF-α) disrupts the gut barrier not only by degradation in TJs, but also through the induction of epithelial apoptosis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Gitter, 2000, Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis, FASEB J source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationTight junction proteins consist of over 50 proteins that are crucial for maintaining cell-to-cell adhesion and gut barrier health.
“TJ proteins consist of over 50 proteins that are crucial for maintaining cell-to-cell adhesion and gut barrier health.36”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] Chiba, 2008, Transmembrane proteins of tight junctions, Biochim Biophys Acta source
Not checked in the free run.
May combine two claims.
PremisecitationThe leak pathway is believed to be regulated by myosin light-chain kinase, where constitutively active MLCK is sufficient to increase the leak pathway-dependent permeability both in vitro and in vivo.
“The leak pathway is believed to be regulated by myosin light-chain kinase (MLCK), where constitutively active MLCK is sufficient to increase the leak pathway–dependent permeability both in vitro and in vivo.52,53”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [52] Shen, 2006, Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure, J Cell Sci source
Not checked in the free run.
- cites [53] Su, 2009, Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis, Gastroenterology source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenThe gut barrier is composed of 3 main interlinked/interdependent layers that provide a physical barrier against bacterial intrusion from the gut lumen.
“The gut barrier is composed of 3 main interlinked/interdependent layers that provides a physical barrier against bacterial intrusion from the gut lumen.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenFunctional or physical disruption of tight junction, adherens junction, and gap junction proteins and desmosomes leads to increased gut permeability causing dysregulated translocation/transportation of inflammatory mediators, which potentially manifests as chronic gut inflammation.
“The functional or physical disruption of TJ, AJ, and gap junction proteins and desmosomes leads to increased gut permeability causing dysregulated translocation/transportation of inflammatory mediators, which potentially manifests as chronic gut inflammation.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe flux that occurs due to cell death (global barrier loss) is classified as the unrestricted pathway, in which there is no size limit of molecules or antigens that can cross the membrane.
“The flux that occurs due to cell death (global barrier loss) is classified as “unrestricted pathway,” in which there is no size limit of molecules or antigens that can cross the membrane.48”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48] Zuo, 2020, Tight junctions as targets and effectors of mucosal immune homeostasis, Cell Mol Gastroenterol Hepatol source
Not checked in the free run.
May combine two claims.
PremisecitationDeletion of AhR in intestinal epithelial cells led to a defective barrier and uncontrolled proliferation of intestinal stem cells, leading to increased tumors in an azoxymethane-DSS-induced colon tumorigenesis model.
“It was demonstrated by the Stockinger group that deletion of AhR in IECs led to a defective barrier and uncontrolled proliferation of intestinal stem cells, leading to increased tumors in an azoxymethane-DSS–induced colon tumorigenesis model.100”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [100] Metidji, 2019, The environmental sensor AHR protects from inflammatory damage by maintaining intestinal stem cell homeostasis and barrier integrity, Immunity source
Not checked in the free run.
May combine two claims.
PremisecitationSupplementation of dietary AhR ligands (like I3C) guarded the intestinal stem cell niche and maintained intestinal barrier function and decreased tumor burden in the azoxymethane-DSS-induced colon tumorigenesis model.
“Supplementation of dietary AhR ligands (like I3C) guarded the intestinal stem cell niche and maintained intestinal barrier function and decreased tumor burden in the azoxymethane-DSS–induced colon tumorigenesis model.100”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [100] Metidji, 2019, The environmental sensor AHR protects from inflammatory damage by maintaining intestinal stem cell homeostasis and barrier integrity, Immunity source
Not checked in the free run.
May combine two claims.
PremisecitationFecal microbiota transplantation has resulted in enhanced metabolic functions of gut microbiota associated with indole alkaloid biosynthesis such as indole-3-acetic acid that in turn enhances gut barrier homeostasis.
“FMT has resulted in enhanced metabolic functions of gut microbiota associated with indole alkaloid biosynthesis such as indole-3-acetic acid that in turn enhances gut barrier homeostasis.91”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [91] Geng, 2018, Faecal microbiota transplantation reduces susceptibility to epithelial injury and modulates tryptophan metabolism of the microbial community in a piglet model, J Crohns Colitis
Not checked in the free run.
May combine two claims.
PremisecitationMicrobial metabolites have been shown to significantly influence the maintenance of gut barrier integrity itself and intestinal homeostasis.
“Further, they have been shown to significantly influence the maintenance of gut barrier integrity itself and intestinal homeostasis.73,74”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [73] Alam, 2018, Role of gut microbiota in intestinal wound healing and barrier function, Tissue Barriers source
Not checked in the free run.
- cites [74] Prochazkova, 2019, Microbiota, microbial metabolites, and barrier function in a patient with anorexia nervosa after fecal microbiota transplantation, Microorganisms source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
PremisecitationThe host-microbiota relationship has been defined as the synergistic effect of microbial metabolites on host immunity, health and disease, energy metabolism, and cellular communication.
“The host-microbiota relationship has been defined as the synergistic effect of microbial metabolites on host immunity, health and disease, energy metabolism, and cellular communication.59, 60, 61, 62, 63,64”
Quote in the paperNot a substantial claim0 of 6 sources checked- cites [59] Jandhyala, 2015, Role of the normal gut microbiota, World J Gastroenterol source
Not checked in the free run.
- cites [60] Thursby, 2017, Introduction to the human gut microbiota, Biochem J source
Not checked in the free run.
- cites [61] Li, 2018, Effects of metabolites derived from gut microbiota and hosts on pathogens, Front Cell Infect Microbiol source
Not checked in the free run.
- cites [62] Araki, 1995, Enhancement of resistance to bacterial infection in mice by vitamin B2, J Vet Med Sci source
Not checked in the free run.
- cites [63] Donia, 2015, Human microbiota. Small molecules from the human microbiota, Science source
Not checked in the free run.
- cites [64] Artis, 2008, Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut, Nat Rev Immunol source
Not checked in the free run.
May combine two claims.
PremisecitationActivation of AhR by tryptophan metabolites promotes immune cell maturation and decreased pathogen colonization.
“Activation of AhR by tryptophan metabolites promotes immune cell maturation and decreased pathogen colonization.89”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Zelante, 2013, Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22, Immunity source
Not checked in the free run.
May combine two claims.
PremisecitationLevels of tight junction proteins in AhR-/- mice are significantly reduced compared with wild type mice leading to increased gut leakiness.
“Levels of TJ proteins in AhR–/– mice are also significantly reduced compared with wild type mice leading to increased gut leakiness.22”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] Singh, 2019, Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway, Nat Commun source
Not checked in the free run.
May combine two claims.
PremisecitationButyrate treatment resulted in downregulation of IL-1β levels, suggesting it may be beneficial for protection against inflammation-promoted barrier disruption.
“Moreover, butyrate treatment resulted in downregulation of IL-1β levels, suggesting it may be beneficial for protection against inflammation-promoted barrier disruption.87”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [87] Diao, 2019, Gastric infusion of short-chain fatty acids can improve intestinal barrier function in weaned piglets, Genes Nutr source
Not checked in the free run.
May combine two claims.
PremisecitationButyrate improved barrier function at lower doses, but reduced barrier function at higher doses in Caco-2 cells.
“Similarly, butyrate improved barrier function at lower doses, but reduced barrier function at higher doses in Caco-2 cells.80”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [80] Peng, 2007, Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier, Pediatr Res source
Not checked in the free run.
May combine two claims.
PremisecitationAt higher concentrations (50-100 mM), sodium butyrate showed no beneficial effects on MUC2 expression patterns, likely due to the induction of apoptosis at higher doses.
“However, at higher concentrations (50–100 mM), it showed no beneficial effects on MUC2 expression patterns,79 likely due to the induction of apoptosis at higher doses.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [79] Nielsen, 2018, Effect of butyrate and fermentation products on epithelial integrity in a mucus-secreting human colon cell line, Journal of Functional Foods source
Not checked in the free run.
May combine two claims.
PremisecitationMicrobial metabolites produced in the gut directly interact with intestinal epithelial cells and immune cells and impact host health.
“Microbial metabolites produced in the gut directly interact with IECs and immune cells and impact host health.61,62”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [61] Li, 2018, Effects of metabolites derived from gut microbiota and hosts on pathogens, Front Cell Infect Microbiol source
Not checked in the free run.
- cites [62] Araki, 1995, Enhancement of resistance to bacterial infection in mice by vitamin B2, J Vet Med Sci source
Not checked in the free run.
May combine two claims.
PremisecitationAhR activation by FICZ was therapeutic in the dextran sodium sulfate-induced mouse colitis model in which FICZ treatment upregulated tight junction protein expression in inflamed mouse colons.
“AhR activation by FICZ was therapeutic in the dextran sodium sulfate (DSS)–induced mouse colitis model in which FICZ treatment upregulated TJ protein expression in inflamed mouse colons.92,93”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [92] Yu, 2018, Aryl hydrocarbon receptor activation modulates intestinal epithelial barrier function by maintaining tight junction integrity, Int J Biol Sci source
Not checked in the free run.
- cites [93] Teng, 2018, Plant-derived exosomal MicroRNAs shape the gut microbiota, Cell Host Microbe source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenIt is estimated that approximately 50,000 microbial metabolites are produced by microbes in the human gut.
“Thus far, it is estimated that ∼50,000 microbial metabolites are produced by microbes in the human gut.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPrimary bile acids, cholic acid and chenodeoxycholic acid, are transported into the gut through the enterohepatic circulation system and are further metabolized by gut microbiota by dehydroxylation, dehydrogenation, and epimerization to generate secondary bile acids.
“These primary bile acids, cholic acid and chenodeoxycholic acid (CDCA), are transported into the gut through the enterohepatic circulation system and are further metabolized by gut microbiota by dehydroxylation, dehydrogenation, and epimerization to generate secondary bile acids reviewed previously.102”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [102] Dawson, 2015, Intestinal transport and metabolism of bile acids, J Lipid Res source
Not checked in the free run.
May combine two claims.
InterpretationreasoningBile acids have been shown to be a double-edged sword and an appropriate balance (ratio) of different bile acids is required to mediate gut barrier protective activity.
“In summary, bile acids have been shown to be a double-edged sword and an appropriate balance (ratio) of different bile acids is required to mediate gut barrier protective activity.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPolyamines exhibit numerous beneficial effects including increased longevity, recovery of injured mucosa, and favorable effects on cognitive function.
“Polyamines exhibit numerous beneficial effects including increased longevity, recovery of injured mucosa, as well as favorable effects on cognitive function.122, 123, 124”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [122] Tofalo, 2019, Polyamines and gut microbiota, Front Nutr source
Not checked in the free run.
- cites [123] Timmons, 2012, Polyamines and gut mucosal homeostasis, J Gastrointest Dig Syst
Not checked in the free run.
- cites [124] Matsumoto, 2011, Longevity in mice is promoted by probiotic-induced suppression of colonic senescence dependent on upregulation of gut bacterial polyamine production, PLoS One source
Not checked in the free run.
May combine two claims.
PremisecitationTreatment with the trans-10 CLA isomer caused a redistribution of ZO-1 and OCLN and increased paracellular permeability in Caco-2 colon epithelial cells.
“Treatment with the trans-10 CLA isomer caused a redistribution of ZO-1 and OCLN and increased paracellular permeability in Caco-2 colon epithelial cells.119”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [119] Roche, 2001, Fatty acids and epithelial permeability: effect of conjugated linoleic acid in Caco-2 cells, Gut source
Not checked in the free run.
May combine two claims.
PremisecitationCLNA1 and CLNA2 significantly reduced inflammatory mediators TNF-α, IL-1β, and IL-6 while upregulating the expression of colonic anti-inflammatory cytokine IL-10 and nuclear receptor peroxisome-activated receptor-γ.
“Additionally, treatment with CLNA1 and CLNA2 significantly reduced inflammatory mediators (TNF-α, IL-1β, and IL-6) while upregulating the expression of the colonic anti-inflammatory cytokine IL-10 and nuclear receptor peroxisome-activated receptor-γ.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMice exposed to broad-spectrum antibiotics such as ampicillin, clindamycin and streptomycin resulted in reduced gut bacterial diversity and richness and impacted gut barrier integrity.
“It was showed that mice exposed to broad-spectrum antibiotics such as ampicillin, clindamycin and streptomycin resulted in reduced gut bacterial diversity and richness and impacted gut barrier integrity.112”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [112] Liu, 2020, Naturally occurring TPE-CA maintains gut microbiota and bile acids homeostasis via FXR signaling modulation of the liver-gut axis, Front Pharmacol source
Not checked in the free run.
May combine two claims.
PremisecitationL. plantarum ZS2058 produced isomers of conjugated fatty acids, α-linolenic acid (CLNA1 and CLNA2), that mitigated DSS-induced colitis by enhancing gut barrier function through upregulation of ZO-1, OCLN, CLDN-3, and E-cadherin 1 in colonic tissues.
“Ren et al reported that the probiotic L. plantarum ZS2058 produced isomers of conjugated fatty acids, α-linolenic acid (conjugated linolenic acid (CLNA) 1 and CLNA2) mitigated DSS-induced colitis by enhancing gut barrier function through upregulation of ZO-1, OCLN, CLDN-3, and E-cadherin 1 in colonic tissues.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTPE-CA treatment induced the expression of tight junction proteins such as ZO-1 and OCLN-associated proteins in these mice and improved the barrier integrity.
“TPE-CA treatment induced the expression of TJ proteins such as ZO-1 and OCLN-associated proteins in these mice and improved the barrier integrity.112”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [112] Liu, 2020, Naturally occurring TPE-CA maintains gut microbiota and bile acids homeostasis via FXR signaling modulation of the liver-gut axis, Front Pharmacol source
Not checked in the free run.
May combine two claims.
PremisecitationThe colons of GP-BAR1-/- mice exhibit altered subcellular distribution of ZO-1, leading to increased gut permeability.
“The colons of GP-BAR1–/– mice exhibit altered subcellular distribution of ZO-1, leading to increased gut permeability.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationUDCA did not alter gut permeability but blocked the DCA-induced permeability in murine jejunal and colonic preparations.
“In contrast, UDCA did not alter gut permeability but blocked the DCA-induced permeability in murine jejunal and colonic preparations.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTreatment with dietary flavanones and their glycosyl derivatives such as total phenolic extracts of Citrus aurantium L (TPE-CA) restored bacterial diversity and improved gut barrier integrity and homeostasis of bile acids.
“Further, treatment with dietary flavanones and their glycosyl derivatives such as total phenolic extracts of Citrus aurantium L (TPE-CA) restored bacterial diversity and improved gut barrier integrity and homeostasis of bile acids.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenTreatment with CDCA decreased the expression of Ocln and TEER values leading to increased permeability as well as an increase in the inflammatory cytokine IL-8.
“Treatment with CDCA decreased the expression of Ocln and TEER values leading to increased permeability as well as an increase in the inflammatory cytokine IL-8.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe effects of DCA and CDCA were mediated by the Src family kinases and were abolished by EGF treatment.
“The effects of these bile acids were mediated by the Src family kinases and was abolished by EGF treatment.110”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [110] Raimondi, 2008, Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation, Am J Physiol Gastrointest Liver Physiol source
Not checked in the free run.
May combine two claims.
PremisecitationUsing a Caco-2 cell model, DCA and CDCA, but not UDCA, treatment decreased TEER and increased permeability.
“Using a Caco-2 cell model, Raimondi et al110 showed that DCA and CDCA, but not UDCA, treatment decreased TEER and increased permeability.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [110] Raimondi, 2008, Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation, Am J Physiol Gastrointest Liver Physiol source
Not checked in the free run.
May combine two claims.
PremisecitationFexaramine, an intestine-restricted FXR agonist, restored intestinal FXR activity and gut barrier integrity in an ALD model.
“Fexaramine, an intestine-restricted FXR agonist, restored intestinal FXR activity and gut barrier integrity in an ALD model.”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
PremisecitationCLNA1 and CLNA2 treatments rebalanced the intestinal microbial composition in the colons of DSS-treated mice, including increasing α-diversity.
“These treatments also rebalanced the intestinal microbial composition in the colons of DSS-treated mice, including increasing the α-diversity.121”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [121] Ren, 2020, c9, t11, c15-CLNA and t9, t11, c15-CLNA from Lactobacillus plantarum ZS2058 ameliorate dextran sodium sulfate-induced colitis in mice, J Agric Food Chem source
Not checked in the free run.
May combine two claims.
PremisecitationCLA treatment reduced the prevalence of Bacteroides and increased Bifidobacterium and Odoribacter in the DSS-induced colitis mouse model.
“Importantly, CLA treatment reduced the prevalence of Bacteroides and increased Bifidobacterium and Odoribacter in this model.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] Chen, 2019, Orally administered CLA ameliorates DSS-induced colitis in mice via intestinal barrier improvement, oxidative stress reduction, and inflammatory cytokine and gut microbiota modulation, J Agric Food Chem source
Not checked in the free run.
May combine two claims.
PremisecitationSome bile acid metabolites can both improve as well as exert negative effects on gut barrier tight junction function.
“Some bile acid metabolites can both improve as well as exert negative effects on gut barrier TJ function.104”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [104] Sarathy, 2017, The Yin and Yang of bile acid action on tight junctions in a model colonic epithelium, Physiol Rep source
Not checked in the free run.
May combine two claims.
Premisenone givenLCA by itself neither altered barrier function nor increased IL-8 production, but LCA attenuated CDCA-induced barrier permeability and IL-8 production.
“Although LCA by itself neither altered barrier function nor increased IL-8 production, LCA attenuated CDCA-induced barrier permeability and IL-8 production.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAmong urolithins, urolithin A displays potent anti-inflammatory, antioxidative, and antiaging properties.
“Among urolithins, urolithin A (UroA) displays potent anti-inflammatory, antioxidative, and antiaging properties.130,133, 134, 135”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [130] Espin, 2013, Biological significance of urolithins, the gut microbial ellagic Acid-derived metabolites: the evidence so far, Evid Based Complement Alternat Med source
Not checked in the free run.
- cites [133] Tomas-Barberan, 2017, Urolithins, the rescue of 'old' metabolites to understand a 'new' concept: metabotypes as a nexus between phenolic metabolism, microbiota dysbiosis and host health status, Mol Nutr Food Res source
Not checked in the free run.
- cites [134] Ryu, 2016, Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents, Nat Med source
Not checked in the free run.
May combine two claims.
PremisecitationA human phase I clinical trial showed that a polyphenol-rich diet modulates gut microbiota and reduces intestinal permeability, including decreased transport of pathogenic microbes into the bloodstream.
“A human phase I clinical trial showed that a polyphenol-rich diet modulates gut microbiota and reduces intestinal permeability, including decreased transport of pathogenic microbes into the bloodstream.150”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [150] Guglielmetti, 2020, Effect of a polyphenol-rich dietary pattern on intestinal permeability and gut and blood microbiomics in older subjects: study protocol of the MaPLE randomised controlled trial, BMC Geriatr source
Not checked in the free run.
May combine two claims.
InterpretationreasoningNumerous microbial metabolites exhibit direct impact on gut epithelium and play an important role in regulating gut barrier function thereby mucosal immunity and vice versa.
“In summary, numerous microbial metabolites discussed previously shown to exhibit direct impact on gut epithelium and play an important role in regulating gut barrier function thereby mucosal immunity and vice versa.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationDietary polyphenols such as isoflavones and lignans and corresponding microbial metabolites protected the gut epithelium by reducing permeability and inhibited LPS-induced inflammation.
“Johnson et al151 reported that dietary polyphenols such as isoflavones and lignans and corresponding microbial metabolites protected the gut epithelium by reducing permeability and inhibited LPS-induced inflammation.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [151] Johnson, 2019, Polyphenol microbial metabolites exhibit gut and blood(-)brain barrier permeability and protect murine microglia against LPS-induced inflammation, Metabolites source
Not checked in the free run.
May combine two claims.
PremisecitationTwo factors are critical for the generation of UroA in humans: presence of UroA producing bacteria and consumption of EA/ET-containing foods.
“Two factors are critical for the generation of UroA in humans (1) presence of UroA producing bacteria and (2) consumption of EA/ET-containing foods (eg, pomegranate, berries, walnuts).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationBacterial polyamines include spermidine, homospermidine, norspermidine, putrescine, cadaverine, and 1,3-diaminopropane with putrescine and spermidine.
“Bacterial polyamines include spermidine, homospermidine, norspermidine, putrescine, cadaverine, and 1,3-diaminopropane with putrescine and spermidine.125”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [125] Michael, 2016, Biosynthesis of polyamines and polyamine-containing molecules, Biochem J source
Not checked in the free run.
May combine two claims.
PremisecitationDepletion of cellular polyamines by α-difluoromethylornithine reduced intracellular free Ca2+ concentrations in normal IECs (IEC-6 cell line), leading to decreased expression of E-cadherin and increased paracellular permeability.
“It was shown that depletion of cellular polyamines by α-difluoromethylornithine reduced intracellular free Ca2+ concentrations in normal IECs (IEC-6 cell line),127 which leads to decreased expression of E-cadherin and increased paracellular permeability.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [127] Guo, 2003, Regulation of adherens junctions and epithelial paracellular permeability: a novel function for polyamines, Am J Physiol Cell Physiol source
Not checked in the free run.
May combine two claims.
PremisecitationExogenous supplementation of spermidine reversed the effects of α-difluoromethylornithine on intracellular Ca2+ and E-cadherin expression and restored paracellular permeability to near normal levels.
“However, exogenous supplementation of the spermidine reversed the effects of α-difluoromethylornithine on intracellular Ca2+ and E-cadherin expression and restored paracellular permeability to near normal levels.128”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [128] Guo, 2005, Polyamines are necessary for synthesis and stability of occludin protein in intestinal epithelial cells, Am J Physiol Gastrointest Liver Physiol source
Not checked in the free run.
May combine two claims.
PremisecitationTreatment with UroA mitigated DSS- or TNBS-induced colitis in mice through enhancing gut barrier function and blocking the production of inflammatory cytokines.
“Importantly, treatment with UroA mitigated DSS- or TNBS-induced colitis in mice through enhancing gut barrier function and blocking the production of inflammatory cytokines.22”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] Singh, 2019, Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway, Nat Commun source
Not checked in the free run.
May combine two claims.
PremisecitationNOD1 and NOD2 knockout mice exhibit increased paracellular permeability and are more susceptible to DSS colitis mediated intestinal injury.
“NOD1 and NOD2 knockout mice exhibit increased paracellular permeability and are reported to be more susceptible to DSS colitis mediated intestinal injury.177”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [177] Natividad, 2012, Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1–/–; Nod2–/– mice, Inflamm Bowel Dis source
Not checked in the free run.
May combine two claims.
PremisecitationThese receptors play crucial roles in host-microbiota interactions and are expressed at various levels in different cell types such as IECs, innate lymphoid cells, macrophages, T cells, and dendritic cells.
“These receptors, which play crucial roles in host-microbiota interactions, are expressed at various levels in different cell types such as IECs, innate lymphoid cells, macrophages, T cells, and dendritic cells.184”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [184] Furusawa, 2013, Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells, Nature source
Not checked in the free run.
May combine two claims.
PremisecitationBlocking TLR4 with antibodies limited acute inflammation in the DSS model but hampered subsequent tissue repair, suggesting an important role for TLR4 in the resolution of inflammation and restoration of tissue integrity.
“Although blocking TLR4 with antibodies limited acute inflammation in the DSS model, subsequent tissue repair was hampered, suggesting an important role for TLR4 in the resolution of inflammation and restoration of tissue integrity.162”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [162] Ungaro, 2009, A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis, Am J Physiol Gastrointest Liver Physiol source
Not checked in the free run.
May combine two claims.
PremisecitationFlagellin exerts activities through TLR5 and plays an essential and nonredundant role in protecting the gut from enteric microbes.
“Flagellin, a structural component of bacterial flagellum, is exerted activities through TLR5 and has been shown to play an essential and nonredundant role in protecting the gut from enteric microbes.164”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [164] Steiner, 2007, How flagellin and toll-like receptor 5 contribute to enteric infection, Infect Immun source
Not checked in the free run.
May combine two claims.
PremisecitationNOD2 deficiency leads to microbial dysbiosis leading to increased risk of colitis.
“Couturier-Millard et al178 reported that NOD2 deficiency leads to microbial dysbiosis leading to increased risk of colitis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [178] Couturier-Maillard, 2013, NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer, J Clin Invest
Not checked in the free run.
May combine two claims.
PremisecitationTLR9-/- mice are more susceptible to DSS-induced colitis compared with wild types mice, suggesting that activation of TLR9 is important for protection against intestinal damage through induction of vascular EGF and intestinal progenitor cell differentiation as well as being critical for wound repair mechanisms.
“TLR9–/– mice are more susceptible to DSS-induced colitis compared with wild types mice, suggesting that activation of TLR9 is important for protection against intestinal damage through induction of vascular EGF and intestinal progenitor cell differentiation as well as being critical for wound repair mechanisms.171”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [171] Rose, 2012, TLR9 is important for protection against intestinal damage and for intestinal repair, Sci Rep source
Not checked in the free run.
May combine two claims.
PremisecitationLPS disrupts junctional protein complexes and increases inflammatory cytokines leading to increased gut permeability.
“Numerous studies including ours showed that LPS disrupts junctional protein complexes and increases inflammatory cytokines leading to increased gut permeability.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMuramyl dipeptide or peptidoglycan mediated activation of NOD2 negatively regulates TLR signaling and provides protection of wildtype mice against colitis.
“Furthermore, muramyl dipeptide or peptidoglycan mediated activation of NOD2 is reported to negatively regulate TLR signaling and provide protection of wildtype mice against colitis.175,176”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [175] Watanabe, 2008, Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis, J Clin Invest
Not checked in the free run.
- cites [176] Macho Fernandez, 2011, Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide, Gut source
Not checked in the free run.
May combine two claims.
PremisecitationIECs express TLR2 that recognizes bacterial lipopeptides, lipoteichoic acid and yeast zymosan, and forms heterodimers with TLR1 or TLR6.
“IECs express TLR2 that recognizes bacterial lipopeptides, lipoteichoic acid and yeast zymosan, and forms heterodimers with TLR1 or TLR 6.157”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [157] Creagh, 2006, TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity, Trends Immunol source
Not checked in the free run.
May combine two claims.
PremisecitationExpression and activation of TLR5 on IECs regulates the composition and localization of microbiota and prevents disease associated intestinal inflammation.
“It was demonstrated in numerous reports from Dr Gewirtz’s group that expression and activation of TLR5 on IECs regulates the composition and localization of microbiota and prevents disease associated intestinal inflammation.165, 166, 167, 168”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [165] Chassaing, 2014, Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice, Gastroenterology source
Not checked in the free run.
- cites [166] Vijay-Kumar, 2007, Deletion of TLR5 results in spontaneous colitis in mice, J Clin Invest
Not checked in the free run.
- cites [167] Leifer, 2014, Linking genetic variation in human Toll-like receptor 5 genes to the gut microbiome's potential to cause inflammation, Immunol Lett source
Not checked in the free run.
May combine two claims.
InterpretationreasoningFunctional immune responses often modulate gut barrier integrity; hence, the fine tuning of gut microbiota to evoke necessary immune responses to alter intestinal barrier function is critical.
“Functional immune responses often modulate gut barrier integrity; hence, the fine tuning of gut microbiota to evoke necessary immune responses to alter intestinal barrier function is critical.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationNod1-/- mice have increased levels of intestinal permeability and inflammation in the murine DSS-induced colitis model compared with wild type mice, suggesting an important role in intestinal barrier function.
“It was reported that Nod1–/– mice have increased levels of intestinal permeability and inflammation in the murine DSS-induced colitis model compared with wild type mice,174 suggesting an important role in intestinal barrier function.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [174] Chen, 2008, The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis, Cancer Res source
Not checked in the free run.
May combine two claims.
Premisenone givenLigand-induced TLR2 activation leads to the specific activation of PKC-α and PKC-δ and is responsible for increased TEER as well as increased apical tightening and sealing of the TJs.
“Ligand-induced TLR2 activation leads to the specific activation of protein kinase C α (PKC-α) and PKC-δ and is responsible for increased TEER as well as increased apical tightening and sealing of the TJs.”
Quote in the paperSubstantial claimMay combine two claims.
PremisereasoningPKC phosphorylation by TLR2 activation leads to stabilization of ZO-1, which is a target of PKC.
“PKC phosphorylation by TLR2 activation leads to stabilization of ZO-1, which is a target of PKC.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe absence of NOD protein-mediated microbial sensing leads to a loss of gut barrier homeostasis and leads to increased susceptibility to gut inflammatory diseases.
“The absence of NOD protein–mediated microbial sensing leads to a loss of gut barrier homeostasis and leads to increased susceptibility to gut inflammatory diseases.176”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [176] Macho Fernandez, 2011, Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide, Gut source
Not checked in the free run.
May combine two claims.
PremisecitationNLRs proteins are responsible for maintaining gut barrier integrity by sensing the presence of commensal microbiota and the regulation of intestinal inflammation.
“NLRs proteins are also responsible for maintaining gut barrier integrity by sensing the presence of commensal microbiota and the regulation of intestinal inflammation.172,173”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [172] Parlato, 2014, NOD-like receptors in intestinal homeostasis and epithelial tissue repair, Int J Mol Sci source
Not checked in the free run.
- cites [173] Yeretssian, 2012, Effector functions of NLRs in the intestine: innate sensing, cell death, and disease, Immunol Res source
Not checked in the free run.
May combine two claims.
PremisecitationActivation of TLR5 by flagellin in ileal tissues of SAMP1/YitFc mice led to decreased epithelial barrier resistance and altered expression of the TJ proteins CLDN-3, OCLN, and ZO-1.
“Activation of TLR5 by flagellin in ileal tissues of SAMP1/YitFc (SAMP) mice (a spontaneous model of Crohn's disease–like ileitis) led to decreased epithelial barrier resistance and altered expression of the TJ proteins CLDN-3, OCLN, and ZO-1.169”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [169] Lopetuso, 2017, Epithelial-specific Toll-like receptor (TLR)5 activation mediates barrier dysfunction in experimental ileitis, Inflamm Bowel Dis source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAnother therapeutic approach includes blocking Th1 responses or using neutralizing antibodies such as infliximab (anti-TNF) antibody.
“Another therapeutic approach includes blocking Th1 responses or using neutralizing antibodies such as infliximab (anti-TNF) antibody.189,190”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [189] Powrie, 1994, Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells, Immunity source
Not checked in the free run.
- cites [190] Noth, 2012, Anti-TNF-alpha antibodies improve intestinal barrier function in Crohn's disease, J Crohns Colitis source
Not checked in the free run.
May combine two claims.
PremisecitationSex hormones such as estrogen and progesterone induced expression of TJ proteins and inhibited gut permeability in inflammatory organoid models from IBD patients and 2D cell line models.
“For example, sex hormones such as estrogen and progesterone induced expression of TJ proteins and inhibited gut permeability in inflammatory organoid models from IBD patients and 2D cell line models.200”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [200] van der Giessen, 2019, A direct effect of sex hormones on epithelial barrier function in inflammatory bowel disease models, Cells source
Not checked in the free run.
May combine two claims.
PremisecitationImplantation of 17 pre-selected clostridial bacterial strains capable of enhancing Treg cell abundance and inducing anti-inflammatory mediators IL-10 and inducible T-cell co-stimulator into GF mice attenuated TNBS-induced colitis and enhanced gut barrier function.
“Implantation of 17 pre-selected clostridial bacterial strains that are capable of enhancing Treg cell abundance and inducing anti-inflammatory mediators, IL-10 and inducible T-cell co-stimulator, into GF mice attenuated TNBS-induced colitis and enhanced gut barrier function.192”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [192] Atarashi, 2013, Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota, Nature source
Not checked in the free run.
May combine two claims.
PremisecitationProgesterone upregulated OCLN expression in the gut and inhibited NF-κB activation to maintain gut barrier homeostasis.
“Zhou et al201 reported that progesterone upregulated OCLN expression in the gut and inhibited NF-κB activation to maintain gut barrier homeostasis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [201] Zhou, 2019, Progesterone decreases gut permeability through upregulating occludin expression in primary human gut tissues and Caco-2 cells, Sci Rep source
Not checked in the free run.
May combine two claims.
PremisecitationUroA and UAS03 blocked unwarranted inflammation and mitigated colitis in pre-clinical models.
“Additionally, UroA and UAS03 also blocked unwarranted inflammation and mitigated colitis in pre-clinical models.22”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] Singh, 2019, Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway, Nat Commun source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
PremisecitationDietary habits and a healthy lifestyle are of the foremost importance in maintaining healthy intestinal barrier functions.
“Last, but definitely not the least, dietary habits and a healthy lifestyle are of the foremost importance in maintaining healthy intestinal barrier functions.207”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [207] Camilleri, 2019, Leaky gut: mechanisms, measurement and clinical implications in humans, Gut source
Not checked in the free run.
May combine two claims.
PremisecitationTreatment with divertin corrected increased intestinal permeability in IL-10-/- mice (spontaneous colitis model) without significant systemic, mucosal, or epithelial toxicity.
“Further, they demonstrated that treatment with divertin corrected increased intestinal permeability in IL-10–/– mice (spontaneous colitis model) without significant systemic, mucosal, or epithelial toxicity.191”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [191] Graham, 2019, Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis, Nat Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationConventional treatment strategies include the use of immunosuppressants such as azathioprine and mesalamine that are used in the clinic to treat ulcerative colitis and Crohn's disease.
“Conventional treatment strategies include the use of immunosuppressants such as azathioprine and mesalamine that are used in the clinic to treat ulcerative colitis and Crohn's disease.188”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [188] Khare, 2019, Mesalamine and azathioprine modulate junctional complexes and restore epithelial barrier function in intestinal inflammation, Sci Rep source
Not checked in the free run.
May combine two claims.
PremisecitationFMT was reported to decrease antibiotic, chemotherapy, and injury-induced gut permeability and increased the prevalence of specific microbiota strains exhibiting anti-inflammatory properties.
“FMT was reported to decrease antibiotic, chemotherapy, and injury-induced gut permeability and increased the prevalence of specific microbiota strains exhibiting anti-inflammatory properties.195,196”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [195] Le Bastard, 2018, Fecal microbiota transplantation reverses antibiotic and chemotherapy-induced gut dysbiosis in mice, Sci Rep source
Not checked in the free run.
- cites [196] Schmidt, 2020, Fecal transplant prevents gut dysbiosis and anxiety-like behaviour after spinal cord injury in rats, PLoS One source
Not checked in the free run.
May combine two claims.
Premisenone givenBeneficial activities of microbial metabolites in regulating gut barrier function have been shown in animal models, but no microbial metabolites or their analogues are in clinical use.
“Though beneficial activities of microbial metabolites in regulating gut barrier function have been shown in animal models, thus far, no microbial metabolites or their analogues are in clinical use.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationProbiotic strains such as L. plantarum elevate the levels of host defense peptides such as pBD2, PG1-5 and pBD2 and improve gut barrier function.
“Furthermore, probiotic strains such as L. plantarum also elevate the levels of host defense peptides such as pBD2, PG1-5 and pBD2 and improve gut barrier function.83”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [83] Feng, 2018, Short-chain fatty acids manifest stimulative and protective effects on intestinal barrier function through the inhibition of NLRP3 inflammasome and autophagy, Cell Physiol Biochem source
Not checked in the free run.
May combine two claims.
PremisecitationOxyberberine ameliorated gut barrier dysfunction via inhibition of the TLR4, MyD88, and NF-κB signaling pathways and downregulated inflammatory cytokines such as TNFα, IL-6, and IL-1β.
“Oxyberberine, another microbial metabolite derived from berberine ameliorated gut barrier dysfunction via inhibition of the TLR4, MyD88, and NF-κB signaling pathways197 and downregulated inflammatory cytokines such as TNFα, IL-6, and IL-1β.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [197] Li, 2020, Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-kappaB pathway, Pharmacol Res source
Not checked in the free run.
May combine two claims.
PremisecitationDietary cellulose supplements can ameliorate LPS-mediated intestinal barrier damage and protect against gut epithelial apoptosis.
“Dietary cellulose supplements also can ameliorate LPS-mediated intestinal barrier damage and protect against gut epithelial apoptosis.205”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [205] Di Caro, 2019, Effect of dietary cellulose supplementation on gut barrier function and apoptosis in a murine model of endotoxemia, PLoS One source
Not checked in the free run.
May combine two claims.
PremisecitationCurcumin supplementation reduced high fat diet induced hepatic steatosis by modulating the gut-liver axis and by enhancing ZO-1 and OCLN expression in the intestines.
“Dietary component such as curcumin supplementation reduced high fat diet induced hepatic steatosis by modulating the gut-liver axis and by enhancing ZO-1 and OCLN expression in the intestines.203”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [203] Yang, 2019, Ellagic acid and its microbial metabolite urolithin a alleviate diet-induced insulin resistance in mice (OR24-03-19), Curr Dev Nutr source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningIncreasing recognition of the association between gut microbes, gut barrier dysfunction, and intestinal diseases highlights the importance of understanding microbial metabolite production and function.
“Moreover, increasing recognition of the association between gut microbes, gut barrier dysfunction, and intestinal diseases highlights the importance of understanding microbial metabolite production and function.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S4 (based).
Interpretationnone givenThe influence of gut microbiota on intestinal barrier permeability and subsequent host cellular homeostasis is indisputable.
“The influence of gut microbiota on intestinal barrier permeability and subsequent host cellular homeostasis is indisputable.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningEmerging knowledge of host-microbiota interactions allows for the development of new therapeutic strategies to restore a healthy gut ecosystem and prevent a variety of intestinal diseases.
“Emerging knowledge of host-microbiota interactions allows for the development of new therapeutic strategies to restore a healthy gut ecosystem and prevent a variety of intestinal diseases.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningA deeper understanding of intestinal microbiota dynamics with respect to gut barrier function provides translational opportunities for therapeutic discovery, including drug design, microbe transplantation, and a clearer perspective of host pathophysiology.
“Furthermore, a deeper understanding of intestinal microbiota dynamics with respect to gut barrier function provides translational opportunities for therapeutic discovery, including drug design, microbe transplantation, and a clearer perspective of host pathophysiology.”
Quote in the paperNot a substantial claim
The authors state this as an assumption.
Gut microbial metabolites, produced in close proximity to gut epithelium, have significant impact on gut barrier function and immune responses.
“Since gut microbial metabolites are produced in close proximity to gut epithelium, presumably they have significant impact on gut barrier function and immune responses.”
The paper relies on this without support.
Intestinal microbial homeostasis is required for maintenance of good health and disease prevention.
“Intestinal microbial homeostasis is required for maintenance of good health and disease prevention.”
The paper relies on this without support.
Reversal of gut dysbiosis is the key factor for any treatment utilizing gut microbiota.
“Reversal of gut dysbiosis is the key factor for any treatment utilizing gut microbiota.”
The paper relies on this without support.
A healthy life without stress, obesity, and diabetes and accompanied by an alcohol-free diet can reverse gut barrier dysfunction over time.
“A healthy life without stress, obesity, and diabetes and accompanied by an alcohol-free diet can reverse gut barrier dysfunction over time.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Butyrate and valerate promote intestinal barrier function, which prevents the translocation of pathogens from the intestine into the bloodstream.
“Butyrate and valerate promote intestinal barrier function, which prevents the translocation of pathogens from the intestine into the bloodstream [45–48].”
From Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization (2023) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Goblet-cell location differs between the text and Table 1
MinorThe text says goblet cells are present in both the small intestine and colon, but Table 1 lists them only in the small intestine.
“whereas enterocytes, goblet cells, and enteroendocrine and tuft cells are present in both the small intestine and colon”
“| Goblet cells (small intestine) |”
Cites
1 retracted
Wang, T., Yao, W., Li, J., Shao, Y., He, Q., Xia, J., & Huang, F. (2020) · Journal of Animal Science and Biotechnology · doi:10.1186/s40104-020-0426-6 · Cited by 51 · see citing works
RetractedStructure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726 · see citing works
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913 · see citing works
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549 · see citing works
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838 · see citing works
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · see citing works
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952 · see citing works
The Human Intestinal Microbiome in Health and Disease
Lynch, S. V., & Pedersen, O. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600266 · Cited by 3,637 · see citing works
Introduction to the human gut microbiota
Thursby, E., & Juge, N. (2017) · Biochemical Journal · doi:10.1042/bcj20160510 · Cited by 3,600 · see citing works
Gut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314 · see citing works
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
Peterson, L. W., & Artis, D. (2014) · Nature reviews. Immunology · doi:10.1038/nri3608 · Cited by 3,191 · see citing works
Bioactive Microbial Metabolites: A Personal View
Bérdy, J. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.1 · Cited by 3,170 · see citing works
Role of the normal gut microbiota
Jandhyala, S. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i29.8787 · Cited by 3,001 · see citing works
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
Mazmanian, S. K., Liu, C. H., Tzianabos, A. O., & Kasper, D. L. (2005) · Cell · doi:10.1016/j.cell.2005.05.007 · Cited by 2,910 · see citing works
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. (2013) · Nature · doi:10.1038/nature12331 · Cited by 2,872 · see citing works
Colonic Health: Fermentation and Short Chain Fatty Acids
Wong, J. M. W., de Souza, R., Kendall, C. W. C., Emam, A., & Jenkins, D. J. A. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200603000-00015 · Cited by 2,739 · see citing works
Zelante, T., Iannitti, R. G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D’Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.003 · Cited by 2,614 · see citing works
Occludin: a novel integral membrane protein localizing at tight junctions.
Furuse, M., Hirase, T., Itoh, M., Nagafuchi, A., Yonemura, S., Tsukita, S., & Tsukita, S. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.6.1777 · Cited by 2,580 · see citing works
Peng, L., Li, Z.-R., Green, R. S., Holzmanr, I. R., & Lin, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.104638 · Cited by 2,130 · see citing works
Furuse, M., Fujita, K., Hiiragi, T., Fujimoto, K., & Tsukita, S. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.7.1539 · Cited by 2,100 · see citing works
Regulation of short-chain fatty acid production
Macfarlane, S., & Macfarlane, G. T. (2003) · Proceedings of the Nutrition Society · doi:10.1079/pns2002207 · Cited by 1,939 · see citing works
Intestinal barrier function: molecular regulation and disease pathogenesis
Groschwitz, K. R., & Hogan, S. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.038 · Cited by 1,775 · see citing works
Control of pathogens and pathobionts by the gut microbiota
Kamada, N., Chen, G. Y., Inohara, N., & Núñez, G. (2013) · Nature Immunology · doi:10.1038/ni.2608 · Cited by 1,625 · see citing works
Treatment of Murine Colitis by <i>Lactococcus lactis</i> Secreting Interleukin-10
Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., & Remaut, E. (2000) · Science · doi:10.1126/science.289.5483.1352 · Cited by 1,513 · see citing works
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499 · see citing works
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
Gopalakrishnan, V., Helmink, B. A., Spencer, C. N., Reuben, A., & Wargo, J. A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.015 · Cited by 1,392 · see citing works
The intestinal epithelial barrier: a therapeutic target?
Odenwald, M. A., & Turner, J. R. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.169 · Cited by 1,288 · see citing works
Dietary lipids, gut microbiota and lipid metabolism
Schoeler, M., & Caesar, R. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09512-0 · Cited by 1,163 · see citing works
Biogeography and individuality shape function in the human skin metagenome
Program, N. C. S., Oh, J., Byrd, A. L., Deming, C., Conlan, S., Kong, H. H., & Segre, J. A. (2014) · Nature · doi:10.1038/nature13786 · Cited by 1,148 · see citing works
Powrie, F., Leach, M. W., Mauze, S., Menon, S., Barcomb Caddle, L., & Coffman, R. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90045-0 · Cited by 1,146 · see citing works
Symbiotic gut microbes modulate human metabolic phenotypes
Li, M., Wang, B., Zhang, M., Rantalainen, M., Wang, S., Zhou, H., Zhang, Y., Shen, J., Pang, X., Zhang, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712038105 · Cited by 1,144 · see citing works
Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut
Artis, D. (2008) · Nature reviews. Immunology · doi:10.1038/nri2316 · Cited by 1,136 · see citing works
CLAUDINS AND EPITHELIAL PARACELLULAR TRANSPORT
Itallie, C. M. V., & Anderson, J. M. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.040104.131404 · Cited by 1,123 · see citing works
The Human Gut Microbiome – A Potential Controller of Wellness and Disease
Kho, Z. Y., & Lal, S. K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01835 · Cited by 1,116 · see citing works
Ryu, D., Mouchiroud, L., Andreux, P. A., Katsyuba, E., Moullan, N., Nicolet-dit-Félix, A. A., Williams, E. G., Jha, P., Lo Sasso, G., Huzard, D., et al. (2016) · Nature Medicine · doi:10.1038/nm.4132 · Cited by 1,105 · see citing works
Leaky gut: mechanisms, measurement and clinical implications in humans
Camilleri, M. (2019) · Gut · doi:10.1136/gutjnl-2019-318427 · Cited by 1,081 · see citing works
Physiology and function of the tight junction
Anderson, J. M., & Van Itallie, C. M. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002584 · Cited by 1,059 · see citing works
Plant-derived exosomal MicroRNAs shape the gut microbiota
Teng, Y., Ren, Y., Sayed, M., Hu, X., Lei, C., Kumar, A., Hutchins, E., Mu, J., Deng, Z., Luo, C., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.10.001 · Cited by 1,027 · see citing works
Self-citationLeclercq, S., Matamoros, S., Cani, P. D., Neyrinck, A. M., Jamar, F., Stärkel, P., Windey, K., Tremaroli, V., Bäckhed, F., Verbeke, K., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415174111 · Cited by 972 · see citing works
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935 · see citing works
The intestinal epithelium: central coordinator of mucosal immunity
Allaire, J. M., Crowley, S. M., Law, H. T., Chang, S.-Y., Ko, H.-J., & Vallance, B. A. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.04.002 · Cited by 933 · see citing works
Intestinal permeability: an overview
Bjarnason, I., Macpherson, A., & Hollander, D. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90708-4 · Cited by 927 · see citing works
Wang, H.-B., Wang, P.-Y., Wang, X., Wan, Y.-L., & Liu, Y.-C. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2259-4 · Cited by 827 · see citing works
Exogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation
Li, Y., Innocentin, S., Withers, D. R., Roberts, N. A., Gallagher, A., Grigorieva, E. F., Wilhelm, C., & Veldhoen, M. (2011) · Cell · doi:10.1016/j.cell.2011.09.025 · Cited by 816 · see citing works
Xenobiotics shape the physiology and gene expression of the active human gut microbiome
Maurice, C. F., Haiser, H. J., & Turnbaugh, P. J. (2013) · Cell · doi:10.1016/j.cell.2012.10.052 · Cited by 811 · see citing works
Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles
Kiss, E. A., Vonarbourg, C., Kopfmann, S., Hobeika, E., Finke, D., Esser, C., & Diefenbach, A. (2011) · Science · doi:10.1126/science.1214914 · Cited by 801 · see citing works
Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells
Ikenouchi, J., Furuse, M., Furuse, K., Sasaki, H., Tsukita, S., & Tsukita, S. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200510043 · Cited by 787 · see citing works
A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease
Braat, H., Rottiers, P., Hommes, D. W., Huyghebaert, N., Remaut, E., Remon, J., van Deventer, S. J. H., Neirynck, S., Peppelenbosch, M. P., & Steidler, L. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.028 · Cited by 786 · see citing works
Lee, J. S., Cella, M., McDonald, K. G., Garlanda, C., Kennedy, G. D., Nukaya, M., Mantovani, A., Kopan, R., Bradfield, C. A., Newberry, R. D., et al. (2012) · Nature Immunology · doi:10.1038/ni.2187 · Cited by 777 · see citing works
TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity
Creagh, E. M., & O’Neill, L. A. J. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.06.003 · Cited by 762 · see citing works
Small molecules from the human microbiota
Donia, M. S., & Fischbach, M. A. (2015) · Science · doi:10.1126/science.1254766 · Cited by 760 · see citing works
Tight junctions/adherens junctions: basic structure and function
Niessen, C. M. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700865 · Cited by 756 · see citing works
Cell Biology of Tight Junction Barrier Regulation and Mucosal DiseasePreprint
Buckley, A., & Turner, J. R. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a029314 · Cited by 725 · see citing works
Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway
Singh, R., Chandrashekharappa, S., Bodduluri, S. R., Baby, B. V., Hegde, B., Kotla, N. G., Hiwale, A. A., Saiyed, T., Patel, P., Vijay-Kumar, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07859-7 · Cited by 713 · see citing works
Self-citationRoles of intestinal epithelial cells in the maintenance of gut homeostasis
Okumura, R., & Takeda, K. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.20 · Cited by 712 · see citing works
Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function
Cario, E., Gerken, G., & Podolsky, D. K. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.056 · Cited by 697 · see citing works
Martini, E., Krug, S. M., Siegmund, B., Neurath, M. F., & Becker, C. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.03.007 · Cited by 668 · see citing works
Electrolyte transport in the mammalian colon: mechanisms and implications for disease
Kunzelmann, K., & Mall, M. (2002) · Physiological Reviews · doi:10.1152/physrev.00026.2001 · Cited by 655 · see citing works
Natividad, J. M., Agus, A., Planchais, J., Lamas, B., Jarry, A. C., Martin, R., Michel, M.-L., Chong-Nguyen, C., Roussel, R., Straube, M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.001 · Cited by 642 · see citing works
Intestinal transport and metabolism of bile acids
Dawson, P. A., & Karpen, S. J. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r054114 · Cited by 598 · see citing works
Berkes, J., Viswanathan, V. K., Savkovic, S. D., & Hecht, G. (2003) · Gut · doi:10.1136/gut.52.3.439 · Cited by 594 · see citing works
Ewaschuk, J. B., Diaz, H., Meddings, L., Diederichs, B., Dmytrash, A., Backer, J., Looijer-van Langen, M., & Madsen, K. L. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90227.2008 · Cited by 590 · see citing works
Espín, J. C., Larrosa, M., García-Conesa, M. T., & Tomás-Barberán, F. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/270418 · Cited by 576 · see citing works
Epithelial crosstalk at the microbiota–mucosal interface
Wells, J. M., Rossi, O., Meijerink, M., & van Baarlen, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000092107 · Cited by 574 · see citing works
NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer
Couturier-Maillard, A., Sécher, T., Rehman, A., Normand, S., Arcangelis, A. D., Häsler, R., Huot, L., Grandjean, T., Bressenot, A., Delanoye, A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62236 · Cited by 571 · see citing works
Peng, L., He, Z., Chen, W., Holzman, I. R., & Lin, J. (2007) · Pediatric Research · doi:10.1203/01.pdr.0000250014.92242.f3 · Cited by 518 · see citing works
Anderson, R. C., Cookson, A. L., McNabb, W. C., Park, Z., McCann, M. J., Kelly, W. J., & Roy, N. C. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-316 · Cited by 510 · see citing works
Larrosa, M., González‐Sarrías, A., Yáñez-Gascón, M. J., Selma, M. V., Azorín‐Ortuño, M., Toti, S., Tomás-Barberán, F. A., Dolara, P., & Espı́n, J. C. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.04.012 · Cited by 505 · see citing works
Wu, W. H., Sun, M., Chen, F., Cao, A., Liu, H., Zhao, Y., Huang, X., Xiao, Y., Yao, S., Zhao, Q., et al. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.114 · Cited by 500 · see citing works
Commensal bacteria make GPCR ligands that mimic human signalling molecules
Cohen, L. J., Esterhazy, D., Kim, S.-H., Lemetre, C., Aguilar, R. R., Gordon, E. A., Pickard, A. J., Cross, J. R., Emiliano, A. B., Han, S. M., et al. (2017) · Nature · doi:10.1038/nature23874 · Cited by 500 · see citing works
Zhang, L., & Davies, S. S. (2016) · Genome Medicine · doi:10.1186/s13073-016-0296-x · Cited by 499 · see citing works
Seeram, N. P., Henning, S. M., Zhang, Y., Suchard, M. A., Li, Z., & Heber, D. (2006) · Journal of Nutrition · doi:10.1093/jn/136.10.2481 · Cited by 477 · see citing works
Feng, Y., Wang, Y., Wang, P., Huang, Y., & Wang, F. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492853 · Cited by 471 · see citing works
Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure
Shen, L., Black, E. D., Witkowski, E. D., Lencer, W. I., Guerriero, V., Schneeberger, E. E., & Turner, J. R. (2006) · Journal of Cell Science · doi:10.1242/jcs.02915 · Cited by 467 · see citing works
Tomás‐Barberán, F. A., González‐Sarrías, A., García‐Villalba, R., Núñez‐Sánchez, M. A., Selma, M. V., García‐Conesa, M. T., & Espín, J. C. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500901 · Cited by 465 · see citing works
Transmembrane proteins of tight junctions
Chiba, H., Osanai, M., Murata, M., Kojima, T., & Sawada, N. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.08.017 · Cited by 464 · see citing works
Su, L., Shen, L., Clayburgh, D. R., Nalle, S. C., Sullivan, E. A., Meddings, J. B., Abraham, C., & Turner, J. R. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.081 · Cited by 455 · see citing works
Cerdá, B., Tomás-Barberán, F. A., & Espı́n, J. C. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf049144d · Cited by 448 · see citing works
Intestinal epithelial claudins: expression and regulation in homeostasis and inflammation
García‐Hernández, V., Quirós, M., & Nusrat, A. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13360 · Cited by 443 · see citing works
Cerd�, B., Esp�n, J. C., Parra, S., Mart�nez, P., & Tom�s-Barber�n, F. A. (2004) · European Journal of Nutrition · doi:10.1007/s00394-004-0461-7 · Cited by 435 · see citing works
Cell death in the gut epithelium and implications for chronic inflammation
Patankar, J. V., & Becker, C. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0326-4 · Cited by 421 · see citing works
Deletion of TLR5 results in spontaneous colitis in mice
Vijay–Kumar, M., Sanders, C. J., Taylor, R. T., Kumar, A., Aitken, J. D., Sitaraman, S. V., Neish, A. S., Uematsu, S., Akira, S., Williams, I. R., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33084 · Cited by 420 · see citing works
Tomás-Barberán, F. A., García-Villalba, R., González-Sarrías, A., Selma, M. V., & Espín, J. C. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf5024615 · Cited by 419 · see citing works
Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon
Shimada, Y., Kinoshita, M., Harada, K., Mizutani, M., Masahata, K., Kayama, H., & Takeda, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080604 · Cited by 404 · see citing works
Metidji, A., Omenetti, S., Crotta, S., Li, Y., Nye, E., Ross, E., Li, V., Maradana, M. R., Schiering, C., & Stockinger, B. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.010 · Cited by 402 · see citing works
Cipriani, S., Mencarelli, A., Chini, M. G., Distrutti, E., Renga, B., Bifulco, G., Baldelli, F., Donini, A., & Fiorucci, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025637 · Cited by 382 · see citing works
Fernandez, E. M., Valenti, V., Rockel, C., Hermann, C., Pot, B., Boneca, I. G., & Grangette, C. (2011) · Gut · doi:10.1136/gut.2010.232918 · Cited by 376 · see citing works
Espín, J. C., González-Barrio, R., Cerdá, B., López-Bote, C., Rey, A. I., & Tomás-Barberán, F. A. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0723864 · Cited by 352 · see citing works
Mucins in the gastrointestinal tract in health and disease
Anthony, P. P. (2001) · Frontiers in bioscience · doi:10.2741/corfield · Cited by 343 · see citing works
Perturbation of Anion Balance during Inhibition of Growth of <i>Escherichia coli</i> by Weak Acids
Roe, A. J., McLaggan, D., Davidson, I., O’Byrne, C., & Booth, I. R. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.4.767-772.1998 · Cited by 331 · see citing works
Watanabe, T., Asano, N., Murray, P. J., Ozato, K., Tailor, P. B., Fuss, I. J., Kitani, A., & Strober, W. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33145 · Cited by 326 · see citing works
Chassaing, B., Ley, R. E., & Gewirtz, A. T. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.033 · Cited by 326 · see citing works
Short‐Chain Fatty Acid Transporters: Role in Colonic Homeostasis
Sivaprakasam, S., Bhutia, Y. D., Yang, S., & Ganapathy, V. (2017) · Comprehensive physiology · doi:10.1002/cphy.c170014 · Cited by 321 · see citing works
The Intestinal Epithelium: Central Coordinator of Mucosal Immunity
Allaire, J. M., Crowley, S. M., Law, H. T., Chang, S., Ko, H., & Vallance, B. A. (2019) · Trends in Immunology · doi:10.1016/j.it.2018.12.008 · Cited by 317 · see citing works
Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells
Yu, A. S. L., McCarthy, K. M., Francis, S. A., McCormack, J. M., Lai, J., Rogers, R. A., Lynch, R. D., & Schneeberger, E. E. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00581.2004 · Cited by 307 · see citing works
Tofalo, R., Cocchi, S., & Suzzi, G. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00016 · Cited by 306 · see citing works
Selma, M. V., Beltrán, D., García-Villalba, R., Espín, J. C., & Tomás-Barberán, F. A. (2014) · Food Funct. · doi:10.1039/c4fo00092g · Cited by 304 · see citing works
Cerdá, B., Periago, P., Espín, J. C., & Tomás-Barberán, F. A. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf050384i · Cited by 301 · see citing works
Matsumoto, M., Kurihara, S., Kibe, R., Ashida, H., & Benno, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023652 · Cited by 290 · see citing works
Hartmann, P., Hochrath, K., Horvath, A., Chen, P., Seebauer, C. T., Llorente, C., Wang, L., Alnouti, Y., Fouts, D. E., Stärkel, P., et al. (2018) · Hepatology · doi:10.1002/hep.29676 · Cited by 290 · see citing works
Raimondi, F., Santoro, P., Barone, M. V., Pappacoda, S., Barretta, M. L., Nanayakkara, M., Apicella, C., Capasso, L., & Paludetto, R. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00043.2007 · Cited by 286 · see citing works
Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protection
García‐Niño, W. R., & Zazueta, C. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.04.008 · Cited by 279 · see citing works
Yu, M., Wang, Q., Ma, Y., Li, L., Yu, K., Zhang, Z., Chen, G., Li, X., Xiao, W., Xu, P., et al. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.22259 · Cited by 274 · see citing works
Duan, F. F., Liu, J. H., & March, J. C. (2015) · Diabetes · doi:10.2337/db14-0635 · Cited by 263 · see citing works
Germ-free and antibiotic-treated mice are highly susceptible to epithelial injury in DSS colitis
Hernández-Chirlaque, C., Aranda, C. J., Ocón, B., Capitán-Cañadas, F., Ortega-González, M., Carrero, J. J., Suárez, M. D., Zarzuelo, A., Sánchez de Medina, F., & Martínez-Augustin, O. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw096 · Cited by 262 · see citing works
Li, C., Ai, G., Wang, Y., Lu, Q., Luo, C., Tan, L., Lin, G., Liu, Y., Li, Y., Zeng, H., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2019.104603 · Cited by 262 · see citing works
The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis
Chen, G. Y., Shaw, M. H., Redondo, G., & Núñez, G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2061 · Cited by 261 · see citing works
Shao, T., Zhao, C., Li, F., Gu, Z., Liu, L., Zhang, L., Wang, Y., He, L., Liu, Y., Liu, Q., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.021 · Cited by 258 · see citing works
Self-citationRegulation of the intestinal epithelial barrier by the apical junctional complex
Laukoetter, M. G., Bruewer, M., & Nusrat, A. (2006) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000203864.48255.4f · Cited by 256 · see citing works
Leaks in the epithelial barrier caused by spontaneous and TNF‐α‐induced single‐cell apoptosis
Gitter, A. H., Bendfeldt, K., Schulzke, J.-D., & Fromm, M. (2000) · The FASEB Journal · doi:10.1096/fj.99-0898com · Cited by 250 · see citing works
Núñez‐Sánchez, M. Á., Garcı́a-Villalba, R., Monedero‐Saiz, T., Espin, N. V. G.-T., Gómez‐Sánchez, M. B., Sánchez‐Álvarez, C., García‐Albert, A. M., Rodríguez‐Gil, F. J., Ruiz‐Marín, M., Pastor-Quirante, F. A., et al. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300931 · Cited by 235 · see citing works
Multitargeted therapy of cancer by ellagitannins
Heber, D. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.043 · Cited by 227 · see citing works
Stenman, L. K., Holma, R., Eggert, A., & Korpela, R. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00267.2012 · Cited by 222 · see citing works
Fort, M. M., Mozaffarian, A., Stöver, A. G., Correia, J. D. S., Johnson, D. A., Crane, R. T., Ulevitch, R. J., Persing, D. H., Bielefeldt-Ohmann, H., Probst, P., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6416 · Cited by 216 · see citing works
González‐Sarrías, A., Giménez‐Bastida, J. A., García‐Conesa, M. T., Gómez‐Sánchez, M. B., García‐Talavera, N. V., Gil‐Izquierdo, A., Sánchez‐Álvarez, C., Fontana‐Compiano, L. O., Morga‐Egea, J. P., Pastor‐Quirante, F. A., et al. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900152 · Cited by 212 · see citing works
Time course production of urolithins from ellagic acid by human gut microbiota
García-Villalba, R., Beltrán, D., Espín, J. C., Selma, M. V., & Tomás-Barberán, F. A. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf402498b · Cited by 207 · see citing works
Russo, E., Giudici, F., Fiorindi, C., Ficari, F., Scaringi, S., & Amedei, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02754 · Cited by 204 · see citing works
Hendrikx, T., & Schnabl, B. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12892 · Cited by 202 · see citing works
High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids
Stenman, L. K. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i9.923 · Cited by 201 · see citing works
Kang, I., Buckner, T., Shay, N. F., Gu, L., & Chung, S. (2016) · Advances in Nutrition · doi:10.3945/an.116.012575 · Cited by 198 · see citing works
Buschmann, M. M., Shen, L., Rajapakse, H., Raleigh, D. R., Wang, Y., Wang, Y., Lingaraju, A., Zha, J., Abbott, E., McAuley, E. M., et al. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-09-0688 · Cited by 192 · see citing works
Tight junctions as targets and effectors of mucosal immune homeostasis
Zuo, L., Kuo, W.-T., & Turner, J. R. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.04.001 · Cited by 191 · see citing works
Chen, Y., Yang, B., Ross, R. P., Jin, Y., Stanton, C., Zhao, J., Zhang, H., & Chen, W. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b05744 · Cited by 185 · see citing works
Alcohol or gut microbiota: who is the guilty?
Meroni, M., Longo, M., & Dongiovanni, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184568 · Cited by 183 · see citing works
Biosynthesis of polyamines and polyamine-containing molecules
Michael, A. J. (2016) · Biochemical Journal · doi:10.1042/bcj20160185 · Cited by 180 · see citing works
Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis
Graham, W. V., He, W., Marchiando, A. M., Zha, J., Singh, G., Li, H.-S., Biswas, A., Ong, M. L. D. M., Jiang, Z.-H., Choi, W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0393-7 · Cited by 176 · see citing works
Transcellular vesicular transport in epithelial and endothelial cells: Challenges and opportunities
Fung, K., Fairn, G. D., & Lee, W. L. (2017) · Traffic · doi:10.1111/tra.12533 · Cited by 175 · see citing works
Maccioni, L., Gao, B., Leclercq, S., Pirlot, B., Horsmans, Y., De Timary, P., Leclercq, I., Fouts, D., Schnabl, B., & Stärkel, P. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1782157 · Cited by 174 · see citing works
Role of gut microbiota in intestinal wound healing and barrier function
Alam, A., & Neish, A. (2018) · Tissue Barriers · doi:10.1080/21688370.2018.1539595 · Cited by 166 · see citing works
Seeram, N. P., Zhang, Y., McKeever, R., Henning, S. M., Lee, R., Suchard, M. A., Li, Z., Chen, S., Thames, G., Zerlin, A., et al. (2008) · Journal of Medicinal Food · doi:10.1089/jmf.2007.650 · Cited by 164 · see citing works
Ungaro, R., Fukata, M., Hsu, D., Hernandez, Y., Breglio, K., Chen, A., Xu, R., Sotolongo, J., Espana, C., Zaias, J., et al. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90496.2008 · Cited by 159 · see citing works
Effects of metabolites derived from gut microbiota and hosts on pathogens
Li, Z., Quan, G., Jiang, X., Yang, Y., Ding, X., Zhang, D., Wang, X., Hardwidge, P. R., Ren, W., & Zhu, G. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00314 · Cited by 157 · see citing works
Tight junction dynamics: the role of junctional adhesion molecules (JAMs)
Garrido-Urbani, S., Bradfield, P. F., & Imhof, B. A. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1820-1 · Cited by 154 · see citing works
Guo, X., Rao, J. N., Liu, L., Zou, T.-T., Turner, D. J., Bass, B. L., & Wang, J.-Y. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00015.2003 · Cited by 153 · see citing works
Linking microbiota to human diseases: a systems biology perspective
Wu, H., Tremaroli, V., & Bäckhed, F. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.09.011 · Cited by 150 · see citing works
Natividad, J. M. M., Petit, V., Huang, X., de Palma, G., Jury, J., Sanz, Y., Philpott, D., Garcia Rodenas, C. L., McCoy, K. D., & Verdu, E. F. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22848 · Cited by 139 · see citing works
Diao, H., Jiao, A. R., Yu, B., Mao, X. B., & Chen, D. W. (2019) · Genes & Nutrition · doi:10.1186/s12263-019-0626-x · Cited by 139 · see citing works
Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health
Ha, C. W. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16498 · Cited by 137 · see citing works
Heller, F., Fromm, A., Gitter, A. H., Mankertz, J., & Schulzke, J.-D. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.46 · Cited by 135 · see citing works
Fecal microbiota transplantation reverses antibiotic and chemotherapy-induced gut dysbiosis in mice
Le Bastard, Q., Ward, T., Sidiropoulos, D., Hillmann, B. M., Chun, C. L., Sadowsky, M. J., Knights, D., & Montassier, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-24342-x · Cited by 134 · see citing works
The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human
Corfield, A. P. (2018) · Microorganisms · doi:10.3390/microorganisms6030078 · Cited by 134 · see citing works
Pavlidis, P., Powell, N., Vincent, R. P., Ehrlich, S. D., Bjarnason, I., & Hayee, B. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13333 · Cited by 132 · see citing works
Bile acid receptors and gastrointestinal functions
Ticho, A. L., Malhotra, P., Dudeja, P. K., Gill, R. K., & Alrefai, W. A. (2019) · Liver Research · doi:10.1016/j.livres.2019.01.001 · Cited by 131 · see citing works
Watanabe, T., Asano, N., Murray, P. J., Ozato, K., Kitani, A., Fuss, I. J., & Strober, W. (2008) · Gastroenterology · doi:10.1016/s0016-5085(08)60085-2 · Cited by 127 · see citing works
Biomarkers of gut barrier failure in the ICU.
Piton, G., & Capellier, G. (2016) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000283 · Cited by 126 · see citing works
Mining the human gut microbiota for effector strains that shape the immune system
Ahern, P. P., Faith, J. J., & Gordon, J. I. (2014) · Immunity · doi:10.1016/j.immuni.2014.05.012 · Cited by 123 · see citing works
Heilman, J. M., Andreux, P. A., Tran, N. L., Rinsch, C., & Blanco-Bose, W. E. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.07.050 · Cited by 122 · see citing works
Saha, P., Yeoh, B. S., Singh, R., Chandrasekar, B., Vemula, P. K., Haribabu, B., Vijay‐Kumar, M., & Jala, V. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156811 · Cited by 121 · see citing works
Self-citationEy, B., Eyking, A., Gerken, G., Podolsky, D. K., & Cario, E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901619200 · Cited by 119 · see citing works
Fecal transplant prevents gut dysbiosis and anxiety-like behaviour after spinal cord injury in rats
Schmidt, E. K. A., Torres-Espin, A., Raposo, P. J. F., Madsen, K. L., Kigerl, K. A., Popovich, P. G., Fenrich, K. K., & Fouad, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0226128 · Cited by 119 · see citing works
Gaya, P., Peirotén, Á., Medina, M., Álvarez, I., & Landete, J. M. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.03.040 · Cited by 116 · see citing works
Nielsen, D. S. G., Jensen, B. B., Theil, P. K., Nielsen, T. S., Knudsen, K. E. B., & Purup, S. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2017.10.023 · Cited by 115 · see citing works
Odenwald, M. A., Choi, W., Kuo, W., Singh, G., Sailer, A., Wang, Y., Shen, L., Fanning, A. S., & Turner, J. R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003908 · Cited by 113 · see citing works
Bi, J., Zhang, J., Ren, Y., Du, Z., Li, T., Wang, T., Zhang, L., Wang, M., Wu, Z., Lv, Y., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14811 · Cited by 113 · see citing works
Wang, W., Xia, T., & Yu, X. (2015) · Inflammation Research · doi:10.1007/s00011-015-0822-0 · Cited by 110 · see citing works
Geng, S., Cheng, S., Li, Y., Wen, Z., Ma, X., Jiang, X., Wang, Y., & Han, X. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy103 · Cited by 107 · see citing works
Johnson, S. L., Kirk, R. D., DaSilva, N. A., Ma, H., Seeram, N. P., & Bertin, M. J. (2019) · Metabolites · doi:10.3390/metabo9040078 · Cited by 100 · see citing works
Microbiota, a key player in alcoholic liver disease
Cassard, A.-M., & Ciocan, D. (2018) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2017.0067 · Cited by 100 · see citing works
Polyamines and Gut Mucosal Homeostasis.
Timmons, J. A., Chang, E. T., Wang, J., & Rao, J. N. (2012) · PubMed · Cited by 97 · see citing works
How flagellin and toll-like receptor 5 contribute to enteric infection
Steiner, T. S. (2007) · Infection and Immunity · doi:10.1128/iai.01506-06 · Cited by 97 · see citing works
Elamin, E. E., Masclee, A., Troost, F. J., Pieters, H., Keszthelyi, D., Aleksa, K., Dekker, J. P., & Jonkers, D. M. A. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107421 · Cited by 96 · see citing works
Konieczna, P., Ferstl, R., Ziegler, M., Frei, R., Nehrbass, D., Lauener, R. P., Akdis, C. A., & O'Mahony, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062617 · Cited by 95 · see citing works
Liu, L., Guo, X., Rao, J. N., Zou, T., Xiao, L., Yu, T., Timmons, J. A., Turner, D. J., & Wang, J.-Y. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00620.2008 · Cited by 94 · see citing works
Guo, X., Rao, J. N., Liu, L., Zou, T., Keledjian, K. M., Boneva, D., Marasa, B. S., & Wang, J.-Y. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00407.2004 · Cited by 93 · see citing works
Prochazkova, P., Roubalova, R., Dvorak, J., Tlaskalova-Hogenova, H., Cermakova, M., Tomasova, P., Sediva, B., Kuzma, M., Bulant, J., Bilej, M., et al. (2019) · Microorganisms · doi:10.3390/microorganisms7090338 · Cited by 93 · see citing works
A direct effect of sex hormones on epithelial barrier function in inflammatory bowel disease models
van der Giessen, J., van der Woude, C. J., Peppelenbosch, M. P., & Fuhler, G. M. (2019) · Cells · doi:10.3390/cells8030261 · Cited by 88 · see citing works
Secretion of insulinotropic proteins by commensal bacteria: rewiring the gut to treat diabetes
Duan, F., Curtis, K. L., & March, J. C. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.01019-08 · Cited by 86 · see citing works
Schulzke, J., & Fromm, M. E. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04925.x · Cited by 85 · see citing works
Shigetomi, K., & Ikenouchi, J. (2017) · The Journal of Biochemistry · doi:10.1093/jb/mvx077 · Cited by 85 · see citing works
TLR9 is important for protection against intestinal damage and for intestinal repair
II, W. A. R., Sakamoto, K., & Leifer, C. A. (2012) · Scientific Reports · doi:10.1038/srep00574 · Cited by 84 · see citing works
Contributions of intestinal epithelial barriers to health and disease
Choi, W., Yeruva, S., & Turner, J. R. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.036 · Cited by 84 · see citing works
Utzeri, E., & Usai, P. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i22.3954 · Cited by 83 · see citing works
Luo, H., Guo, P., & Zhou, Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046291 · Cited by 82 · see citing works
Duan, C., Kuang, L., Xiang, X., Zhang, J., Zhu, Y., Wu, Y., Yan, Q., Liu, L., & Li, T. (2020) · Aging · doi:10.18632/aging.102690 · Cited by 82 · see citing works
Carvalho, F. A., Aitken, J. D., Gewirtz, A. T., & Vijay-Kumar, M. (2011) · Mucosal Immunology · doi:10.1038/mi.2010.57 · Cited by 80 · see citing works
NOD-like receptors in intestinal homeostasis and epithelial tissue repair
Parlato, M., & Yeretssian, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069594 · Cited by 79 · see citing works
Zhou, Z., Bian, C., Luo, Z., Guille, C., Ogunrinde, E., Wu, J., Zhao, M., Fitting, S., Kamen, D. L., Oates, J. C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44448-0 · Cited by 78 · see citing works
Polyamines and Gut Mucosal Homeostasis
Timmons, J. (2013) · Journal of Gastrointestinal & Digestive System · doi:10.4172/2161-069x.s7-001 · Cited by 78 · see citing works
Expression and functional importance of innate immune receptors by intestinal epithelial cells
Marques, R., & Boneca, I. G. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0829-9 · Cited by 76 · see citing works
Toll like receptor-5: protecting the gut from enteric microbes
Vijay–Kumar, M., Aitken, J. D., & Gewirtz, A. T. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0100-5 · Cited by 75 · see citing works
Manipulation of epithelial integrity and mucosal immunity by host and microbiota‐derived metabolites
Kayama, H., & Takeda, K. (2020) · European Journal of Immunology · doi:10.1002/eji.201948478 · Cited by 74 · see citing works
The Yin and Yang of bile acid action on tight junctions in a model colonic epithelium
Sarathy, J., Detloff, S. J., Ao, M., Khan, N., French, S., Sirajuddin, H., Nair, T., & Rao, M. C. (2017) · Physiological Reports · doi:10.14814/phy2.13294 · Cited by 72 · see citing works
Trends in the search for bioactive microbial metabolites
Ōmura, S. (1992) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/bf01569759 · Cited by 71 · see citing works
Investigating Gut Permeability in Animal Models of Disease
González-González, M., Díaz-Zepeda, C., Eyzaguirre‐Velásquez, J., González‐Arancibia, C., Bravo, J. A., & Julio‐Pieper, M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01962 · Cited by 71 · see citing works
Khare, V., Krnjic, A., Frick, A., Gmainer, C., Asboth, M., Jimenez, K., Lang, M., Baumgartner, M., Evstatiev, R., & Gasche, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-39401-0 · Cited by 70 · see citing works
Recent advances in bioactive microbial secondary metabolites.
UMEZAWA, H. (1977) · PubMed · Cited by 68 · see citing works
Anti-TNF-α antibodies improve intestinal barrier function in Crohn's disease
Noth, R., Stüber, E., Häsler, R., Nikolaus, S., Kühbacher, T., Hampe, J., Bewig, B., Schreiber, S., & Arlt, A. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.10.004 · Cited by 68 · see citing works
Liu, L., Liu, Z., Li, H., Cao, Z., Li, W., Song, Z., Li, X., Lu, A., Lu, C., & Liu, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00012 · Cited by 68 · see citing works
Fatty acids and epithelial permeability: effect of conjugated linoleic acid in Caco-2 cells
Roche, H. M., Terres, A. M., Black, I. B., Gibney, M. J., & Kelleher, D. (2001) · Gut · doi:10.1136/gut.48.6.797 · Cited by 67 · see citing works
Crosstalk between the immune receptors and gut microbiota
Mu, C., Yang, Y., & Zhu, W. (2015) · Current Protein & Peptide Science · doi:10.2174/1389203716666150630134356 · Cited by 66 · see citing works
Short‐Chain Fatty Acid Transporters: Role in Colonic Homeostasis
Sivaprakasam, S., Bhutia, Y. D., Yang, S., & Ganapathy, V. (2018) · Comprehensive physiology · doi:10.1002/j.2040-4603.2018.tb00009.x · Cited by 63 · see citing works
Han, B., Sheng, B., Zhang, Z., Pu, A., Yin, J., Wang, Q., Yang, K., Sun, L., Yu, M., Qiu, Y., et al. (2016) · Shock · doi:10.1097/shk.0000000000000594 · Cited by 62 · see citing works
Wang, Y., Yang, J., Wang, W., Sanidad, K. Z., Cinelli, M. A., Wan, D., Hwang, S. H., Kim, D., Lee, K. S. S., Xiao, H., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916189117 · Cited by 59 · see citing works
Metidji, A., Omenetti, S., Crotta, S., Li, Y., Nye, E., Ross, E., Li, V., Maradana, M. R., Schiering, C., & Stockinger, B. (2019) · Immunity · doi:10.1016/j.immuni.2019.05.024 · Cited by 54 · see citing works
Yang, J., Guo, Y., Henning, S. M., Chan, B. C., Long, J., Zhong, J., Acín‐Pérez, R., Petcherski, A., Shirihai, O. S., Heber, D., et al. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000091 · Cited by 53 · see citing works
Guglielmetti, S., Bernardi, S., Del Bo’, C., Cherubini, A., Porrini, M., Gargari, G., Hidalgo-Liberona, N., Gonzalez-Dominguez, R., Peron, G., Zamora-Ros, R., et al. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-1472-9 · Cited by 51 · see citing works
Toll-like receptor-4 mediates intestinal barrier breakdown after thermal injury
Peterson, C. Y., Costantini, T. W., Loomis, W. H., Putnam, J. G., Wolf, P., Bansal, V., Eliceiri, B. P., Baird, A., & Coimbra, R. (2010) · Surgical Infections · doi:10.1089/sur.2009.053 · Cited by 47 · see citing works
Enhancement of resistance to bacterial infection in mice by vitamin B2
ARAKI, S., SUZUKI, M., FUJIMOTO, M., & KIMURA, M. (1995) · Journal of Veterinary Medical Science · doi:10.1292/jvms.57.599 · Cited by 45 · see citing works
Effector functions of NLRs in the intestine: innate sensing, cell death, and disease
Yeretssian, G. (2012) · Immunologic Research · doi:10.1007/s12026-012-8317-3 · Cited by 37 · see citing works
Ren, Q., Yang, B., Zhang, H., Ross, R. P., Stanton, C., Chen, H., & Chen, W. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c00573 · Cited by 37 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193 · see citing works
Benedé-Ubieto, R., Cubero, F. J., & Nevzorova, Y. A. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2331460 · Cited by 242 · see citing works
The function of gut microbiota in immune-related neurological disorders: a review
Sittipo, P., Choi, J., Lee, S., & Lee, Y. K. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02510-1 · Cited by 221 · see citing works
Horrocks, V., King, O. G., Yip, A. Y. G., Marques, I. M., & McDonald, J. A. K. (2023) · Microbiology · doi:10.1099/mic.0.001377 · Cited by 104 · see citing works
Yip, A. Y. G., King, O. G., Omelchenko, O., Kurkimat, S., Horrocks, V., Mostyn, P., Danckert, N., Ghani, R., Satta, G., Jauneikaite, E., et al. (2023) · doi:10.1101/2023.03.25.533086 · Cited by 91 · see citing works
Benameur, T., Porro, C., Twfieg, M.-E., Benameur, N., Panaro, M. A., Filannino, F. M., & Hasan, A. (2023) · Brain Sciences · doi:10.3390/brainsci13081226 · Cited by 60 · see citing works
A review of mathematical modeling of bone remodeling from a systems biology perspective
Cook, C. V., Lighty, A. M., Smith, B. J., & Ford Versypt, A. N. (2024) · Frontiers in Systems Biology · doi:10.3389/fsysb.2024.1368555 · Cited by 25 · see citing works
Wei, J., Liu, C., Qin, D., Ren, F., Duan, J., Chen, T., & Wu, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102544 · Cited by 15 · see citing works
- Authors
- Ghosh, S., Whitley, C. S., Haribabu, B., & Jala, V. R.
- Affiliations
- University of Louisville (US)
- Corresponding author
- Jala, Venkatakrishna Rao
- Venue
- Cellular and Molecular Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2021
- Volume
- 11
- Issue
- 5
- Pages
- 1463-1482
- ISSN
- 2352-345X (ISSN-L)
- PMC
- PMC8025057
- OpenAlex
- W3129925389
- Semantic Scholar
- 90f802cea558abb11387de76fdcedb31c6e57f46
- Cited by
- 835
- References
- 211
- Citations by year
- 2026: 168 · 2025: 229 · 2024: 192 · 2023: 130 · 2022: 89 · 2021: 27
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cellular and Molecular Gastroenterology and Hepatology (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Nutrition and Physiology
- Keywords
- intestinal barrier function, gut microbiota, microbial metabolites, intestinal epithelium, host-microbe interactions, immune regulation, dietary metabolites, dysbiosis, probiotics
- MeSH terms
- Gastrointestinal Microbiome, Animals, Cell Membrane Permeability, Humans, Intestinal Mucosa, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review